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                                     INTRODUCTION 
 Siddha system of medicine which has been araised from South India is the 
traditional medicine. Among all the system of medicines in India it has uniqueness in 
diagnosing the disease and treating it. 
 Siddha system of medicine not only cures the disease but also plays a major role 
in increasing the immune system.  
 The herbal preparation of the Siddha medicine can be given right from birth to 
prevent the illness. 
 Thereby its plays a major role in pediatric age group by increasing their immune 
power. And moreover it is not harmful to their body and has no side effects. It also 
prevents them from further infections. 
 Children become ill easier since they aren‟t built with a proper immune system. 
And moreover they are prone to several pathogens from the surrounding environment. 
 Among these they are easily affected by Acute Naso-Pharyngitis (Common cold). 
 The symptoms of Acute Naso Pharyngitis are cold, running nose, fever, rumbling 
noise in stomach, diarrhea, fatigue which are compared to the symptoms of Neer Kana 
Maantham in the Siddha literature Bala Vagadam.  
 URIT‟s are extremely common in children on an average of 6-8 times a year. 
Peak prevalence in Children aged between 2-10years. 
The frequency of Acute Naso pharyngitis varies due to exposure, such as                    
spending more time in indoors, near an infected person and specifically for children, they 
acquire at schools. 
  Acute Naso pharyngitis is the inflammation of nasal passage on the upper part of 
pharynx. 
            Cold last for 1week. Mild cold last for 2/3 days. Severe cold may last for upto  
2 weeks.  
            Most common infectious agents include various viruses and bacteria. 
Among this Rhino viruses are the most important viruses which cause at least one-
half of the cold. They can multiple only inside the living cells.  
Children have close contact with their parents and other adults and children. 
Young children are not able to practice good personal hygiene such as washing the hands 
properly etc. New born acquire temporary cold from their mother. 
         Common cold can lead to the development of other diseases like pneumonia, 
asthma, acute bronchitis. There is currently no cure for the common cold. Treatment 
involves in relieving the symptoms and to keep the body as healthy as possible.  
           In modern system of medicine, it is most commonly prescribed by medications 
such as antibiotics and anti-histamines with cough suppressants. 
           But, long term use of antibiotics is associated with many side effects like dizziness, 
headache, vomiting, drowsiness and skin rashes. 
            Doctors may prescribe a course of board-spectrum antibiotics for 3-5days, which 
fight a range of bacteria and also cause the loss of good flora of the gut. 
In Siddha system of medicine, it is mostly treated by herbs which as no side 
effects and it prevent the body from getting affected by further infections. 
Bala vagadam a literature in Siddha system deals with the children diseases. It is 
one of the books of Pediatric in Siddha system which describes from birth to late 
childhood. It also explains about the treatments of each pediatric disease under the herbal 
formulation which is safe for the child and also helps in increasing their immune power 
by preventing them from further infections. 
          Maantham one of the disease affecting the child from the age group of 3months to 
12years is explained. It is classified into 21types in the text Bala vagadam.  
          As per the Siddha literature NEER KANA MAANTHAM is one of the types of 
Maantham which is caused due to the derangements of the three humours (Vatha, Pitha, 
and Kapha) in mother which affects the children also. 
         It affects the upper respiratory tract causing fever, irritation of throat, lack of 
appetite. It gives more trouble to the children under the age group of 2-12years. 
        In this condition mostly children are prone to antibiotics which become resistant on 
continuous consumption and need a higher dosage for recovery which affect the children 
in future. 
 So the author tries to evaluate a Siddha herbal formulation Manjanaathi Kudineer 
Chooranam mentioned in “Bala Vagadam” for the treatment of “Neer Kana 







































 AIM AND OBJECTIVE 
AIM : 
       The aim of the study is the management of NEER KANA MAANTHAM 




       To review the literature of the disease Neer Kana Maantham in Siddha aspect 
and Modern aspect. 
       To compare the etiology, incidence, clinical features, treatment, prognosis and 
complications of Neer Kana Maantham with Acute Naso Pharyngitis (Common 
Cold) in Modern science. 
       To know the predominance of disease age, sex, climate, family history, diet 
and socio economic status are considered. 
       To study the Neer Kana Maantham based on Siddha parameters such as 
dearanged mukkuttram, poripulangal, ezhu udar kattukal and envagai thervugal. 
       To evaluate the Pharmacological activity- Anti microbial activity for the trial 
drug Manjanaathi Kudineer . 
       To evaluate the Bio chemical analysis, Physico chemical analysis, Phyto 
chemical analysis of the trial drug Manjanaathi Kudineer . 
       To evaluate the Toxicological analysis – Acute toxicity of the trial drug 
Manjanaathi Kudineer . 
       To have the clinical trial of Neer Kana Maantham with trial drug Manjanaathi 

















































வ஬று பத஦ர்கள்  
              ஥ாந்஡ம், அனசம், அனசகம் ஋ண திள்ளபப் தி஠ி 
஥ருத்து஬ த௄னில் குநிப்திடப்தட்டுள்பது. 
 
இ஦ல் 
 ஥ந்஡ இ஦ல்பு உளட஦து ஥ாந்஡ம் ஋ணப்தடும். 
 ஥ாந்஡ம் ஋ன்தது உரு஬ ஢ிளன஦ில் உடல் ஢ிளன஦ில் 
஥ந்஡ம். 
 அரு஬ ஢ிளன஦ில் அகக்கரு஬ிகபாகி஦ ஥ணம், புத்஡ி, 
சித்஡ம், அகங்கா஧ம் ஆகி஦ அளணத்து அந்஡க்க஧஠ங் 
கபிலும் ஥ந்஡ம் ஋ண கு஫ந்ள஡ ஥ருத்து஬த்஡ில் 
கூநப்தட்டுள்பது. 
 உண்ட உ஠வு சசரி஦ா஥ல் ஬஦ிற்நில் புபித்து ஬஦ிறு 
உப்தி இள஧ந்து ஥ந்஡த்ள஡ உண்டாக்கி ஬ாந்஡ிள஦ம௃ம், 
க஫ிச்சளனம௃ம் உண்டாக்கி துன்தத்ள஡    ஌ற்தடுத்தும் 
ந஢ாய் ஋ண திள்ளபப்தி஠ி ஥ருத்து஬த்஡ில் 
குநிப்திடப்தட்டுள்பது. 
 
வ஢ாய் ஬ரும் தரு஬ம்: 
 இந்ந஢ாய் ஡ானப்தரு஬ம், சப்தா஠ிப்தரு஬ம், முத்஡ப் 
தரு஬ம், ஬ருளகப்தரு஬ங்கபில் உண்டாகக் கூடி஦  
ந஢ாய்கபாகும். 
 கு஫ந்ள஡஦ின் மு஡னாண்டினிருந்து மூன்று ஆண்டுகள் 
஬ள஧த் ச஡ாடரும் ஋ண கு஫ந்ள஡ ஥ருத்து஬ம் ஥ற்றும் 
஡ன்஬ந்஡ிரி கு஫ந்ள஡ ஬ாகடத்஡ில் உள்பது. 
 இந்ந஢ாய் 3 ஥ா஡ம் மு஡ல் 12 ஬஦து ஬ள஧ ஬஧க்கூடி஦து.  
 தால் ஥ட்டும் குடிக்கும் தரு஬ம், தாலும் நசாறும் 
உண்ணும் தரு஬ம், நசாறு ஥ட்டும் உண்ணும் தரு஬ம்  
ஆகி஦ மூன்று தரு஬ங்கபில் ஥ாந்஡ம் ஌ற்தடும் ஋ண 
திள்ளபப்தி஠ி ஥ருத்து஬த்஡ில் குநிப்திடப்தட்டு 
உள்பது. 
வ஢ாய் ஬ரும் ஬஫ி :  
 கு஫ந்ள஡ திநந்஡ எரு ஆண்டிற்குள் ஢ீர் ஢ிளனகபில் 
தழுத்து உ஡ிர்ந்஡ சருகுகள் ஬ிழுந்து அழுகி஦ிருக்கும் 
஢ீள஧க்குடிப்த஡ாலும். 
 ஋ருள஥ப்தால், புபித்஡ ஋ருள஥ ந஥ார், ஋ருள஥ ச஢ய், 
஬ாள஫ப்த஫ம், ஥ாம்த஫ம், ந஡ங்காய், இப஢ீர், கடளன, 
ச஬ல்னம், காட்டுத்து஬ள஧, ச஥ாச்ளசக்சகாட்ளட, 
புபி஦ங்சகாட்ளட, தருப்புருண்ளட, ஥ா஬ிணாற் 
சசய்஦ப்தட்ட சதாருள்கள், அ஡ி஧சம், ஬ாம௃ப் 
சதாருட்கள், நசாறு இள஬களப அ஡ிக஥ாக 
உண்த஡ாலும் ஥ாந்஡ ந஢ாய் உண்டாம் ஋ண கு஫ந்ள஡ 
஥ருத்து஬ம் குநிப்திடுகிநது. 
 தாகற்காய்கள், ஊன், சதரி஦ உல௃ள஬஥ீன், 
஬ாளப஥ீன், தன்நி, ஬஧ால் ஥ீன், சகண்ளட஥ீன் 
இள஬களப உண்த஡ாலும் ஥ாந்஡ ந஢ாய் உண்டாகும் 
஋ண திள்ளபப்தி஠ி ஥ருத்து஬த்஡ில் குநிப்திடுகிநது. 
 ந஥ா஡ிதால், ச஢ய், க஡னித஫ம், இப஢ீர், ந஡ங்காய், 
புபித்஡ ந஥ார், ஥ா஥ிசம், கணிகள், உல௃ந்து, ச஥ாச்ளச, 
புபி஦ங்சகாட்ளட, உல௃ள஬, சகண்ளட ஥ீன், தாகல், 
சுள஧ மு஡னாண ஬ாம௃ப்தண்டங்களப தால் 
சகாடுக்கும் ஥ா஡ர்கள் ஥ிகு஡ி஦ாக உண்டால் ந஢ாய்  
உண்டாகும் ஋ண ஆ஬ி அபிக்கும் அமு஡ முளந 
சுருக்கத்஡ில் குநிப்திடப்தட்டுள்பது. 
 உ஠஬ிணால் ஥ட்டு஥ின்நி சச஦னின் ந஬று 
தாட்டாலும் ஥ாந்஡ ந஢ாய் கு஫ந்ள஡ள஦த் ஡ாக்கும். 
஬றுள஥, தசி, து஦஧ம், ஥ணக்க஬ளன, த஦ம், நகாதம், 
இச்ளச நதான்ந உ஠ர்வுகபால் கு஫ந்ள஡஦ாணது 
஡ாக்குறும் நதாது உ஠வு சசரிக்கும் ஡ன்ள஥஦ில் 
஥ாறுதாடு ஢ிகழ்ந்து ஥ாந்஡ம் உண்டாகிநது ஋ண 
திள்ளபப்தி஠ி ஥ருத்து஬ம்  த௄ல் கூறுகிநது. 
 ந஥லும் நசாறு ஥ட்டும் உண்ணும் தரு஬த்஡ில் 
கு஫ந்ள஡஦ின் உ஠வு குற்நத்஡ிணாலும் உ஠஬ின் 
ந஬றுதாட்டாலும் ஥ாந்஡ம் ஌ற்தடும். 
 கு஫ந்ள஡஦ின் தூய்ள஥஦ற்ந ஡ன்ள஥, சரி஦ாண 
ந஢஧த்஡ில் சாப்திடாது ந஢஧ந்஡஬நி சாப்திடல், 
சுத்஡஥ற்ந உ஠வுப் சதாருட்களபச் சாப்திடல், 
உ஠஬ில் நதா஡ி஦ ஊட்டச்சத்து இல்னா஡ ஢ிளன 
ஆகி஦ கா஧஠ங்கபிணாலும் இந்ந஢ாய் ஬ரும். 
 
உ஠வுப்த஫க்கத்஡ால் ஥ாந்஡ம் வ஡ான்று஡ல் : 
஬ா஡ம் : 
          ச஥ாணன் – உண்ணும்  உ஠஬ின் சசரி஥ாணத்஡ிற்கு உ஡வுகிநது. 
தித்஡ம் : 
        அணற்தித்஡ம் –உ஠வுப்சதாருள்கபின் சசரி஥ாணத்஡ிற்கு 
மு஡ன்ள஥ தங்கு ஬கிக்கிநது. 
கதம் :  
       கிவன஡கம் – உண்ணும் உ஠஬ிளண ச஥த்ச஡ண சசய்ம௃ம். 
இக்குற்நங்கபின் தா஡ிப்தால் ஥ாந்஡ம் ஌ற்தடுகிநது. 
வ஢ாய் ஬கககள் : 
            கு஫ந்ள஡ ஥ருத்து஬த்஡ில் ஥ாந்஡ ந஢ாய் 21 ஬ளககபாகப் 
திரிக்கப்தட்டுள்பது.  
 1.  ஬பி ஥ாந்஡ம் 
 2.  அ஫ல் ஥ாந்஡ம் 
 3.  ஍஦ ஥ாந்஡ம் 
 4.  ஬ிட ஥ாந்஡ம் 
 5.  நதார் ஥ாந்஡ம் 
 6.  ஬ாளன ஥ாந்஡ம் 
 7.  சு஧ ஥ாந்஡ம் 
 8.  ஢ீர் ஥ாந்஡ம் 
 9.  சசரி஦ா ஥ாந்஡ம் 
10. கட்டு ஥ாந்஡ம் 
11. தால் ஥ாந்஡ம் 
12. ஋ரி ஥ாந்஡ம் 
13. துளன ஥ாந்஡ம் 
14. ஡ளன ஥ாந்஡ம் 
15. க஠ ஥ாந்஡ம் 
16. ஬னிப்பு (இழுப்பு) ஥ாந்஡ம் 
17. சு஫ி ஥ாந்஡ம் 
18. முக்கு ஥ாந்஡ம் 
19. சந்஢ி ஥ாந்஡ம் 
20. ஊ஡ல் ஥ாந்஡ம் 
21. ஬கீ்க ஥ாந்஡ம் 
இத்துடன் இன்னும் 10 ஬ளக குநிப்திடப்தட்டுள்பது 
1. உப்தன் ஥ாந்஡ம் 
2. ஬ாந்஡ி ஥ாந்஡ம் 
3. ஬நட்சி ஥ாந்஡ம் 
4. ஡ிட்டு ஥ாந்஡ம் 
5. உளப ஥ாந்஡ம் 
6. அக்க஧ ஥ாந்஡ம் 
7. நதய் ஥ாந்஡ம் 
8. ஢ீர்க்க஠ ஥ாந்஡ம் 
9. ந஡ாட ஥ாந்஡ம் 
10.கருப்த ஥ாந்஡ம் 
 
஥ற்சநாரு ஬ளகப்தாட்டின் தடி 8 ஬ளகப்தடும்.  
1. சதாது ஥ாந்஡ம் 
2. சசரி஦ா ஥ாந்஡ம் 
3. ஡ளன ஥ாந்஡ம் 
4. நதார் ஥ாந்஡ம் 
5. கட்டு ஥ாந்஡ம் 
6. ஬ிட ஥ாந்஡ம் 
7. ஢ீர் ஥ாந்஡ம் 
8. சு஫ி ஥ாந்஡ம் 
஡ன்஬ந்஡ிரி தான஬ாகடத்஡ில் ஥ாந்஡ ந஢ாய் 21 ஬ளக஦ாக 
திரிக்கப்தட்டுள்பது.  
1. அ஫ல் ஥ாந்஡ம் 
2. ஊ஡ல் ஥ாந்஡ம் 
3. ஋ரி ஥ாந்஡ம் 
4. ஍஦ ஥ாந்஡ம் 
5. க஠ ஥ாந்஡ம் 
6. சந்஢ி ஥ாந்஡ம் 
7. சு஧ ஥ாந்஡ம் 
8. கரி ஥ாந்஡ம் 












அனுத஬ க஬த்஡ி஦ வ஡஬஧ட்சி஦த்஡ில் 8 ஬கககள்                          
1. சசரி஦ா ஥ாந்஡ம் 
2. தரீ் ஥ாந்஡ம் 
3. சு஧ ஥ாந்஡ம் 
4. ஬ி஭ ஥ாந்஡ம் 
5. சு஫ி ஥ாந்஡ம் 
6. ஊது ஥ாந்஡ம் 
7. ஢ீர் ஥ாந்஡ம் 
8. ஡ளன ஥ாந்஡ம் 
஥஡கன நூனில் ஥ாந்஡ம் 13 ஬கககபாகப் திரிக்கப் தட்டு 
உள்பது 
  (கும்த முணி தான஬ாகடம்) 
“ந஡ான்நி ஬ா஡ தித்஡ம் சசால்னி஦ சிசனற்த ஥ாந்஡ம் 
  ஊன்நி஦஡டுக்கு ஥ாந்஡ம்஬ிச ஥ாந்஡ம் நதார்஥ாந்஡ம் ஡ான் 
  கன்நி஦தால் ஥ாந்஡ம் ஬ன்கத ஥ாந்஡ம் சதாது ஥ாந்஡ம் தின் 
  ஬ந்஡ிடும் ஬ிளண஦ாம் சன்ணி ஬னி சாத்஡ி த஡ிமூன்நா஡ாந஥”. 
அள஬ : 
           1. ஬ா஡ ஥ாந்஡ம் 
           2.  தித்஡஥ாந்஡ம் 
           3.  சிநனற்தண ஥ாந்஡ம் 
           4. ஢டுக்கு ஥ாந்஡ம் 
           5. ஬ி஭ ஥ாந்஡ம் 
           6. நதார் ஥ாந்஡ம் 
           7. தால் ஥ாந்஡ம் 
           8. ஬ங்கத ஥ாந்஡ம் 
           9. சதாது ஥ாந்஡ம் 
         10.஬ிளண ஥ாந்஡ம் 
         11.சன்ணி ஥ாந்஡ம் 
         12.஬னி ஥ாந்஡ம் 
         13.சாத்஡ி ஥ாந்஡ம் 
திள்கபப்தி஠ி ஥ருத்து஬ம் தாகம் 2-ல் ஥ாந்஡த்஡ின் ஬ளககள் – 53 
                         43 ஬ளக ஥ாந்஡ங்கள் குநி கு஠ ஬ிபக்கங்கல௃டன் 
கா஠ப்தடுகின்நண. 
                        ஥ீ஡முள்ப 10 ஥ாந்஡ங்கள் சத஦஧ப஬ில் ஥ட்டும் 
஬ளகப்தடுத்஡ப் தட்டுள்பத்து. 
 
பதாது குநிகு஠ங்கள் : 
 கு஫ந்ள஡஦ின் உடம்பு கணத்஡ல், ந஢ா஡ல். 
 ஬ிடா சு஧ம் 
 ஥ிகு஡ி஦ாண ஬ி஦ர்ள஬ உண்டா஡ல் 
 கண் கு஫ி ஬ிழுந்து, ஬ி஫ி சி஬ந்து காணும். 
 முகம் ச஬ல௃த்து எரு ஬ளக ஥ங்கி஦ எபி காணும். 
 கு஧ல் ஡ாழ்ந்து கா஠ப்தடும். 
 ஡ா஦ிணிடம் தால் உண்஠ாது. 
 சீ஡மும் ஥னமு஥ாகவும், சகட்டுநதாணதால் நதானவும், ஡ண்஠ரீ் 
நதானவும் ஢ிந஥ாக நத஡ி஦ா஡ல். 
 ளக கால்கள் சூடு இல்னா஥ல் குபிர்ந்து கா஠ல் 
 கு஫ந்ள஡ ளக஦ில் ஡ங்கா஥ல் அழு஬ந஡ாடு  துள்ல௃ம். 
 அடிக்கடி ஬ாந்஡ி, தசி஦ின்ள஥ ஌ற்தடும். 
 உடம்தில் எரு஬ி஡ ச஬ப்பு ஢ாற்நம் உண்டாகும். 






஢ீர்க்க஠ ஥ாந்஡ம் குநிகு஠ம் 
                      “இருமு மூக்கில் ஢ீர்஬டிம௃ம் 
                              இளட஦ில் இளட஦ில் சு஧ங்காம௃ம் 
                      சதாரு஥ி ஬஦ிறு இள஧ச்சலுண்டாம் 
                               நதா஡ப் தன஬ி஡ ஥ாய்க்க஫ிம௃ம் 
                       சசாருகுங் கண்ணும் உடம்புமுகம் 
                                நசார்ந்து ஡ளனம௃ம் பு஧ட்டலுண்டாம் 
                       ஥ரு஬ி ஥஦க்கம் உண்டாக்கும் 
                                ஬ருகு ஢ீர்க்க஠ ஥ாந்஡முந஥”. 
                                                    - கு஫ந்ள஡ ஥ருத்து஬ம் (தான஬ாகடம்-தக்கம்-179) 
குநிகு஠ங்கள் : 
1. இரு஥ல் 
2. மூக்கில் ஢ீர் ஬டி஡ல் 
3. சு஧ம் 
4. க஫ிச்சல் 
5. உடல், முகம் நசார்஬ளட஡ல் 
6. ஬஦ிறு இள஧ச்சல் 







2. மூக்கில் ஢ீர் ஬டி஡ல் 
3. இளட஦ில் சு஧ங்காம௃ம் 
4. சதாரு஥ி ஬஦ிறு இளநச்சலுண்டாம் 
5. தன஬ி஡஥ாய்க் க஫ிம௃ம் 
6. ஥஦க்கம் 
7. கண், முகம், உடம்பு நசார்ந்து நதாகும். 
சித்஡ ஥ருத்து஬ வ஢ாய் க஠ிப்பு  
 தி஠ி஦நிமுளநள஥ 
 உ஦ிர் ஡ாதுக்கள் (முக்குற்நம்)  
 உடல் ஡ாதுக்கள் (஌ழு உடற்கட்டுகள்) 
 தரு஬ கானங்கள் 
 ஍஬ளக ஢ினங்கள் 




   ந஥ற்குநி஦ கா஧஠ிகபின் ஥ாறுதாடுகளப என்றுடன் என்று 
எப்திட்டு ந஢ாய் க஠ிக்கப்தடுகிநது. 
தி஠ி஦நிமுகநக஥: 
 சதாநி஦ால் அநி஡ல் 
 புனணால் அநி஡ல் 
 ஬ிணாவு஡ல் 
 
஢ீர்க்க஠ ஥ாந்஡த்஡ில் வ஢ா஦ாபிக்கு காணும் 
குநிகு஠ங்கள்: 
1. பதாநி஦ால் அநி஡ல் 
           மூக்கு – மூக்கு ஢ீர் தாய்஡ல் 
           ஢ா – இ஦ல்பு 
           கண்   – சினந஬ளப கண் சி஬த்஡ல் 
           காது   – இ஦ல்பு 
           ந஡ால் – இ஦ல்பு 
2. புனணால் அநி஡ல் 
          ஊறு    – இ஦ல்பு 
          ஏளச  – இ஦ல்பு 
          எபி     – இ஦ல்பு 
          சுள஬ – இ஦ல்பு 
          ஢ாற்நம் – மூக்கில் சபி சவ்வு ஡டித்஡ல் 
 
3. ஬ிணாவு஡ல் 
                                   ஥ருத்து஬ர் ந஢ா஦ாபி஦ிடம் ஬ிணாவு஡ல் மூனம் 
ந஢ாள஦க் க஠ிக்க முடிம௃ம். ந஢ா஦ாபி஦ால் நதச முடி஦ா஡ ந஢஧த்஡ில் 
அ஬ன் சுற்நத்஡ாரிடம் ஬ிணாவு஡ல் மூனம் ந஢ாள஦க் க஠ிக்க 
முடிம௃ம்.   
உ஦ிர் ஡ாதுக்கள் : 
         “஥ந்஡஥னாது ஬ாம௃஬஧ாது” 
- ந஡஧ன் நசக஧ப்தா 
இ஡ில் ஥ந்஡த்஡ிணால் ஬ாம௃ உண்டாகும் ஋ண அநி஦னாம். 
ந஥லும்    
      “஢டுங்கி஦வ஡ார் தித்஡஥து வகாதங் பகாண்டு 
                    ஢ல்ன஬ாம௃க஬ தற்நி ஦ழுத்஡ிக் பகாள்ல௃ம்” 
- தான ஬ாகடம் 
 மு஡னில் தித்஡ந஡ாடம் தா஡ிப்தளடந்து (஡ன்ணிளன ஬பர்ச்சி 
அளடந்து) தின்பு ஬பிகுற்நத்஡ின் ச஡ா஫ிளனம௃ம் (ந஬ற்று஢ிளன 
஬பர்ச்சி அளடந்து) தா஡ிக்கும். 
 
I. ஬ா஡ம்  
 ஢ீர்க்க஠ ஥ாந்஡த்஡ில்   
1. தி஧ா஠ன் – இ஦ல்பு 
2. அதாணன் – தா஡ிப்பு (சின ந஬ளப க஫ிச்சல் கா஠ல்) 
3. ஬ி஦ாணன் – தா஡ிப்பு (உடல் குன்று஡ல்) 
4. உ஡ாணன் – தா஡ிப்பு ( இரு஥ல் காணு஡ல்) 
5. ச஥ாணன் – தா஡ிப்பு ( தசி஦ின்ள஥ கா஠ல்) 
6. ஢ாகன் – இ஦ல்பு 
7. கூர்஥ன் – இ஦ல்பு 
8. கிருக஧ன் – தா஡ிப்பு (இரு஥ல், மூக்கில் ஢ீர் ஬டி஡ல்) 
9. ந஡஬஡த்஡ன் – இ஦ல்பு 
10. ஡ணஞ்சச஦ன்-   -- 
 
II. தித்஡ம்  
        ஢ீர்க்க஠ ஥ாந்஡த்஡ில் 
1. அணற்தித்஡ம் – தா஡ிப்பு (தசி஦ின்ள஥ கா஠ல்) 
2. இ஧சக தித்஡ம் – தா஡ிப்பு (முகம் ச஬ல௃த்து கா஠ல்) 
3. சா஡க தித்஡ம் – தா஡ிப்பு (உடல் நசார்வு கா஠ல்) 
4. தி஧ாசகம் – இ஦ல்பு 
5. ஆநனாசகம் – இ஦ல்பு 
 
III. கதம்  
      ஢ீர்க்க஠ ஥ாந்஡த்஡ில் 
1. அ஬னம்தகம் – தா஡ிப்பு ( இரு஥ல் கா஠ல்) 
2. கிநன஡கம் – தா஡ிப்பு (சசரி஦ாள஥) 
3. நதா஡கம் – இ஦ல்பு 
4. ஡ற்தகம் – தா஡ிப்பு (சினந஬ளப கண் சி஬த்஡ல்) 
5. சந்஡ிகம் – இ஦ல்பு 
உடற்஡ாதுக்கள் 
                     உண்ட உ஠஬ின்  அன்ணசா஧஥ாணது குடனில் 
உநிஞ்சப்தட்டு உடற் ஡ாதுக்கபாண சா஧ம், சசந்஢ீர், ஊன், 
சகாழுப்பு, ஋ன்பு, மூளப, சுக்கினம் / சுந஧ாணி஡ம் நதான்ந஬ற்ளந 
நதாட஠ிக்கிண்நது.  
  ஢ீர்க்க஠ ஥ாந்஡த்஡ில் உடற்கட்டுகபின் ஢ிளன 
1. சா஧ம்    – தா஡ிப்பு (உடற்நசார்வு கா஠ல்) 
2. சசந்஢ீர் – தா஡ிப்பு ( முகம் ச஬ல௃த்துக் கா஠ல்) 
3. ஊன்      – இ஦ல்பு 
4. சகாழுப்பு – இ஦ல்பு 
5. ஋ன்பு – இ஦ல்பு 
6. மூளப – இ஦ல்பு 







                 ப஢ய்஡ல் ஥ற்றும் குநிஞ்சி ஢ினப்தகு஡ிகபில் ஢ீர்க்க஠ 








                 கார்க்கானம் ஥ற்றும் கூ஡ிர்க்கானம்- ஢ீர்க்க஠ ஥ாந்஡ 
ந஢ாய் ஡ாக்கம் அ஡ிக஥ாக கா஠ப்தடுகிநது. 
                 கதக்குற்நம் அ஡ிகரித்து ஡ணக்கு துள஠஦ாக ஬ா஡, தித்஡க் 
குற்நத்ள஡ அ஡ிகரித்து இந்ந஢ாய் உண்டாகிநது. 
 
எண்஬கக வ஡ர்வு 
       “஢ாடி தரிசம் ஢ா஢ிநம் ப஥ா஫ி஬ி஫ி 
              ஥னம் மூத்஡ி஧஥ிக஬ ஥ருத்து஬஧ாம௃஡ம்”. 
- ந஢ாய் ஢ாடல் மு஡ல் தாகம். 
஢ீர்க்க஠ ஥ாந்஡த்஡ில் 
1. ஢ா- இ஦ல்பு 
2. ஢ிநம் – முகம் ச஬ல௃த்துக்கா஠ல் 
3. ச஥ா஫ி –கு஧ல் எனி ஡ாழ்஡ல் 
4. ஬ி஫ி – சினந஬ளப கண் சி஬த்஡ல் 
5. ஥னம் – சினந஬ளப க஫ிச்சல் கா஠ல் 
6. மூத்஡ி஧ம் – இ஦ல்பு 
7. தரிசம் – ஥ி஡ ச஬ப்தம் 
8. ஢ாடி – ஬ா஡தித்஡ம், ஬ா஡கதம், தித்஡கதம் 
஢ீர்க்குநி  
     “அருந்து஥ாநி ஧஡மும் அ஬ிந஧ா஡஥ாய் 
      அஃகல் அனர்஡ல் அகானவூன் ஡஬ிர்த்஡஫ற் 
      குற்நப஬ருந்஡ி உநங்கி ள஬களந 
     ஆடிக் கனசத் ஡ா஬ிந஦ காதுசதய் 
      ச஡ாரு முகூர்த்஡க் களனக்குட்தடு ஢ீரின் 
     ஢ிநக்குநி ச஢ய்க்குநி ஢ிரு஥ித்஡ல் கடநண”. 
                                                        -ந஢ாய் ஢ாடல் ந஢ாய் மு஡ல்஢ாடல் தகு஡ி - 1 
஬ிபக்கம்  
        ஢ீர்க்குநி தார்க்கும் மு஡ல் ஢ாள் இ஧வு ஢ன்கு உ஠வு உண்டு உநங்க 
ந஬ண்டும். தின் ஬ிடி஦ற்காளன தடிக தாத்஡ி஧த்஡ில் ஢ீரிளணப் திடித்து 
அ஡ன் ஢ீர்க்குநி ஥ற்றும் ஢ிநக்குநி஦ிளண கண்டநி஡ல் ந஬ண்டும். 
             “஬ந்஡ ஢ீர் கரிப஦கட ஥஠ம் நுக஧ எஞ்சபனன் 
                             கநந்஡ி஦லுபக஬ ஦கநகுது முகநவ஦.” 
- ந஢ாய் ஢ாடல் மு஡ல் தாகம்.  
                       ஢ீரில்  ஢ிநம், ஥஠ம், த௃ள஧, ஋ளட, ஋ஞ்சல் ஆகி஦஬ற்ளந 
ந஢ாக்க ந஬ண்டும். 
ப஢ய்க்குநி 
                   கு஫ந்ள஡கபின் ஢ாடி ஢ளட சரி஦ாக க஠ிப்த஡ில் சி஧஥ம் 
உள்ப஡ால், ச஢ய்க்குநி தரிநசா஡ளண மூனம் ந஢ா஦ாபர் 
஋க்குற்நத்஡ால் தா஡ிக்கப்தட்டுள்பார் ஋ன்த஡ளண க஠ிக்கனாம். 
          “஢ிநக்குநிக் குள஧த்஡ ஢ிரு஥ா஠ ஢ீரிற் 
            சிநக்க ச஬ண்ச஠ய்ந஦ார் சிறுதுபி ஢டு஬ிடுத் 
            ச஡ன்றுநத் ஡ிநந்ச஡ானி ந஦ாகா ஡ள஥ந்஡஡ி 
            ணின்ந ஡ி஬ளன நதாம் ச஢நி஬ி஫ி஦நிம௃ம் 
            சிறு஢ீரில் ஢ல்சனண்ச஠ய்  ஬ிட்டு தார்ப்தது.” 
                                                        -ந஢ாய் ஢ாடல் ந஢ாய் மு஡ல்஢ாடல் தகு஡ி - 1 
ந஢ா஦ாபி஦ின் சிறு஢ீள஧ நசா஡ளண ஬ட்டில் ஊற்நி சூரி஦ எபி ஥ிகுந்஡ 
இடத்஡ில் ஢ீரின் அளன஦ில்னா஡ நதாது ஢ல்சனண்ச஠ய்த் துபி 
஬ிட்டு தார்ப்தது. 
              “அ஧ப஬ண ஢ீண்டிணஃவ஡ ஬ா஡ம் 
                ஆ஫ி வதாற் த஧஬ின் தித்஡ம் 
                முத்ப஡ாத்து ஢ிற்கின் கதம்”. 
 
஬ிபக்கம் : 
     ஬ா஡ ஢ீர் – தாம்பு நதால் த஧வும் 
     தித்஡ ஢ீர் - ந஥ா஡ி஧ம் நதால் த஧வும் 
     கத ஢ீர் – முத்து நதால் த஧வும் 
஢ாடி ஢கட  



























 MODERN ASPECT 
RESPIRATORY SYSTEM 
     Respiratory system is one of the important system in our body, which plays major role 
in respiration. It is divided into upper and lower airways. The upper respiratory tract 
includes nose, para nasal sinus, pharynx, larynx. Lower respiratory tract includes trachea, 
bronchi, bronchioles and alveoli. 
                     
UPPER RESPIRATORY TRACT 
     Upper Respiratory Tract refers to the parts of respiratory system lying above the 
sternal angle, above the glottis. It includes the nose, nasopharynx  and oropharynx. It 
plays main role in fighting with the infection which affects the human being through oral 
and mucosal route. 
                                        
ANATOMY AND PHYSIOLOGY OF                                                             
UPPER RESPIRATORY TRACT 
NOSE 
      The nose is the visible part of the respiratory system. 
      Protruding prominently from the face, the nose serves as a vent for air exchange and 
also as the organ of smell. 
      The structures of the nose are divided into two main parts,  
                  External nose and 
                  Internal nasal cavity 
     External nose has a skeletal frame work that is  
o Partly bone 
o Partly cartilaginous 
     The bones are the nasal bones which form the bridge of the nose and the frontal 
process of the maxillae. 
       The cartilages are the superior and inferior nasal cartilages, the septal cartilages and 
some small cartilages. 
       The nasal cavity extends from the external nares to the posterior nasal apertures. It is 
sub divided into right and left halves by a midline nasal septum. 
Each half has a :   
            Floor – separates it from oral cavity, formed by the hard palate 
            Roof - narrow and formed by the 
                                  Body of sphenoid 
                                  Cribriform plate of ethmoid bone 
                                  Frontal bone 
                                Nasal bone and cartilage 
      Lateral wall – shows three horizontal bony projections, covered by mucous 
membrane, the superior, middle and inferior conchae. 
 
      Medial wall (septum)- Osteocartilagenous partition, covered by the mucoperiosteum. 
          Formed by Superiorly – the vertical plate of ethmoid bone 
                            Posteriorly – the vomer bone 
                            Anteriorly – the septal cartilage 
ARTERIAL SUPPLY  
      Anterior ethmoidal artery 
      Posterior ethmoidal artery 
      Sphenopalatine artery 
      Greater palatine artery 
      Superior labial artery 
VENOUS SUPPLY 
      Lateral Nasal veins from alae 
NERVE SUPPLY 
        Trigeminal nerve 
        Anterior superior ophthalmic nerve 
       Anterior inferior maxillary nerve  





                                        PHARYNX  
     The pharynx is a wide muscular tube, situated behind the nose, the mouth and the 
larynx. 
     Length : About 12cm 
     Width : Upper part is widest and collapsible (3.5cm) 
                  Middle part is narrow 
                  Lower end is the narrowest of the gastro intestinal tract 
    Clinically it is a part of the upper respiratory tract where the infections are common. 
    It is divided into 3 parts  
             Nasopharynx  
                         It is the upper part which is situated behind the nose and above the lower 
border of soft palate and it transmits only air. 
            Oropharynx  
                          It is the middle part of the pharynx situated behind the oral cavity and it 
transmits both air and food. 
           Laryngopharynx  
                          It is the lower part which extends from the upper border of epiglottis to 
the lower border of cricoid cartilage and it transmit only food. 
                        
BOUNDARIES  
     Superiorly – Base of the skull 
                          Posterior part of the body of sphenoid 
                          Basilar part of the occipital bone 
                          In front of the pharyngeal tubercle 
     Inferiorly – Continuous with oesophagus 
                        Lower border of cricoid cartilage 
     Posteriorly – Prevertebral fossa 
    Anteriorly – It communicates with the nasal cavity, oral cavity and larynx. The anterior 
wall of pharynx is incomplete. 
    Laterally – It communicates with Middle ear cavity 
 Mandible 
 Tongue 
 Pterigoid plate 
 Hyoid bone 
 Thyroid 
MUSCLES  
     The muscular basis of the wall of the pharynx is formed by 3 pairs of constrictors 
namely, 
    Superior constrictor 
    Middle constrictor 
   Inferior constrictor 
NERVE SUPPLY  
        Pharyngeal branch of the vagus 
        Pharyngeal branch of the glosso pharyngeal nerve‟ 
        Pharyngeal branch of the superior cervical sympathetic ganglion 
        Cranial accessory nerve 
        Maxillary nerve 
ARTERIAL SUPPLY 
       Ascending pharyngeal branch of the external carotid artery. 
       Ascending palatine and tonsilar branches of the facial artery. 
       Dorsal lingual branches of the lingual artery. 
       The greater palatine pharyngeal and pterigoid branches of maxillary artery. 
VENOUS SUPPLY 
       Internal jugular vein 
       Facial vein 
LYMPHATICS  
       Retropharyngeal , deep cervical lymph nodes. 
 PHYSIOLOGY : 
     The functions of nose are 
              Provides an airway for respiration 
              Moistens and warms entering air 
              Filters inspired air and cleanses it of foreign matter 
               Serves as a resonating chamber for speech 
               Houses the olfactory (smell) receptors 
  The functions of pharynx are 
               Respiration 
              Swallowing 
              Language formation 
              Protective function 
















               Acute naso pharyngitis is commonly known as cold. It is an inflammation of the 
mucous membranes of the upper pharynx, the naso pharynx or the naso pharyngeal duct 
which extends between the oral and nasal palate. It is also referred as upper respiratory 
infection or rhinitis. It is very common pathology among children and adolescent. 
ETIOLOGY : 
          It may be due to infective and non-infective cause. Non infective cause like allergic 
to food, low socio economic status, dust allergy, environmental changes like pollution, 
climate change and family history can cause naso pharyngitis. A virus or bacteria causes 
infective naso pharyngitis. Although viruses causes most acute nasopharyngitis episodes, 
group A streptococcus causes 37% of infection in children older than 5years, other 
bacterial cause of infection are group C streptococcus (5%), anaerobic species (1%). 
Between viruses Rhino virus, Corona virus and Adeno virus account for the 30% of total 
case. It can spread through tiny air droplets that are expelled when a person infected with 
sneezes. 
EPIDEMOLOGY : 
        Common cold(Acute Naso pharyngitis) which comes under Acute Respiratory Tract 
Infections is very common and constitutes major cause of childhood morbidity.        
        Colds are frequent and recurring problem. Children in preschool and elementary 
school can have 6-12 colds per year. The common cold occurs most frequently during the 
rain fall, winter and spring season. 
       On an average, a child in urban area during first five years of life may suffer from 5-
8episodes of ARI per year. In rural areas the reported incidence per child is lower 
(1episodes per year). 
       The infection is transmitted either by direct contact with infected secretions or by 
inhaling the airborne virus after individuals sneeze or cough. 
       The incubation period of the organism is 2-5days. 
       Among this RVs are the most common occurring in 25-80%of cases and Coronavirus 
10-20%, Influenza virus 10-15% of cases, 5%of cases occur by adenovirus. 
PATHOLOGY : 
         The symptoms of common cold are believed to be primarily related to the immune 
response to the virus. The mechanism of this immune response is virus specific. For 
example, the rhinovirus is typically acquired by direct contact; it binds to human ICAM-I 
receptors through unknown mechanism to trigger the release of inflammatory mediators. 
These inflammatory mediators then produce the symptoms. It does not generally cause 
damage to the nasal epithelium. The respiratory syncytial virus (RSV) on the other hand, 
is contracted by direct contact and airborne droplets. It then replicates in the nose and 
throat before frequently spreading to the lower respiratory tract. Respiratory syncytial 
virus cause epithelium damage. Human Para influenza virus typically results in 
inflammation of the nose, throat and bronchi. In young children when it affects the 
trachea it may produce the symptoms of croup due to the small size of their airways. 
CLINICAL MANIFESTATION: 
IN YOUNG CHILDREN: 
       In general children 3months-3years have fevers in the early course of infection. 
       Few hours before onset of fever, sneezing, irritability and restlessness present. 
       Nasal discharge begins within few hours quickly leading to nasal obstruction. 
       A few infant may vomit and some have diarrhea. 
 
 
IN OLDER CHILDREN: 
      The initial symptoms are dryness and irritation in the nose, these symptoms follow 
with in few hours. 
      Watery nasal discharge. 
      Sneezing 
      Coughing 
      Muscular aches 
      Head aches 
      Malaise 
      Anorexia 
      Low grade fever may be present. 
COMPLICATIONS: 
       Sinus infection (acute sinusitis). It is characterized by inflammation and swelling of 
the mucous membranes that line sinus cavities 
       Asthma  
       Acute bronchitis (Chest cold) 
       Sore throat and tonsillitis 
       Acute suppurative otitis media 



























TRAIL DRUG – MANJANAATHI KUDINEER 
 
 
                      
 





TRIAL DRUG - INGREDIENTS 
                             
Thippili (Piper Longum)                       Milagu (Piper Nigrum) 
                     
Chukku (Zingiber Officinale)                Notchi ilia (Vitex Negundo) 
                            
Vasambu (Acorus Calamus)                  Nuna ilai (Morinda Tinctoria) 
                                                                 
                            





   




        
                                           நு஠ா 
                         
Botanical Name - Morinda Tinctoria 
English Name – Indian Mulberry 
Family – Rubiaceae 
Used part - Leaves 
சுக஬ – கார்ப்பு 
஡ன்க஥ – ச஬ப்தம் 
திரிவு – கார்ப்பு  
            “தட்ளட காப்தசணாடு தா஧ச்சி நனஷ்஥சு஧ம் 
              எட்டி஢ின்ந புண்கி஧ந்஡ி எட்டுங்காண் – ஥ட்டனள஧ 
              ஌ந்து நு஠ா஬ின் இகன஥ந்஡ம் ஡ரீ்த்து ஢ல்ன 
              காந்஡ி஡ரு ந஥க஥டுங் காண்”. 
CHEMICAL CONSTITUTENTS : morindin, morindone 
ACTIONS : Tonic, Febrifuge, Emmenagogue 
PHARMACOLOGICAL ACTIVITES : Anti microbial, Anti inflammatory, Anti 
oxidant 
                                    
ப஢ாச்சி 
                             
Botanical Name - Vitex Negundo 
English Name – Five leaved chaste tree 
Family – Laminaceae 
Used part - Leaves 
சுக஬ – ளகப்பு, து஬ர்ப்பு, கார்ப்பு 
஡ன்க஥ – ச஬ப்தம் 
திரிவு – கார்ப்பு  
           “ந஢ா஦ா கனிள஦ ச஢ாடிக்கு பருந்஡ ச஬ல்னம் 
            ந஦ா஦ா ஥஠ால௃ மு஦ர்த்து஡லுக் – கா஦ 
            ஬ந்஡மு஡ல் ஢ண்தாகி ஬ா஡த்ள஡ ந஦ம௃ந஬ாற் 
            சிந்து஬ா ஧ங்கணலுந் ஡ீ”. 
CHEMICAL CONSTITUTENTS : Viridiflorol, p-caryophylene, 4-terpineol 
ACTIONS : Expectorant, Aletrnative, Vermifuge 
PHARMACOLOGICAL ACTIVITES : Anti microbial, Anti inflammatory 
                                     
 
உத்஡ா஥஠ி 
Botanical Name - Pergularia Daemia 
English Name – Dog‟s bane whitelow plant 
Family –  Asclepiadaceae 
Used part - Leaves 
சுக஬ – ளகப்பு 
஡ன்க஥ – ச஬ப்தம் 
திரிவு – கார்ப்பு 
            “ஆனித் ச஡ழுந்஡ந஢ாய் அத்஡ளண ம௃ந்஡ீருந஥ 
              ந஬னிப் தருத்஡ி஦஡ின் ச஥ல்இளன஦ால் – ந஬சனாத்துக் 
              கண்டிக்கும் ஬ா஡ங் கடுஞ்சன்ணி ந஡ாடமும்நதாம் 
              உண்டிக்கும் ஬ாசளண஦ாம் ஏது. 
             உத்஡ா ஥஠ி஦ிளன஦ால் உள்஬஦ிற்றுக் குன்ம்ச஥ாடு 
            குத்஡ாம் ஬னிம௃ங் குபிரும்நதாம் – தற்நி 
            இசிக்கும் ஬னி஦ிள஧ப்பும் ஋த்஡டிப்பும் ஌கும் 
            தசிக்கு஥஡ி ஥ாந்஡மும்நதாம் தார்”. 
 
CHEMICAL CONSTITUTENTS : pergularin 
ACTIONS : Expectorant, Anthelmintic, Emetic 
PHARMACOLOGICAL ACTIVITES : Anti inflammatory, Antipyretic, Analgesic 
க஫ற்சி 
Botanical Name - Caesalpinia Bonduc  
English Name – Bonduc Nut, Moloucca Bean, Physic Nut 
Family – Fabaceae 
Used part - Leaves 
சுக஬ – ளகப்பு 
஡ன்க஥ – ச஬ப்தம் 
திரிவு – கார்ப்பு  
          “஬ிள஧஬ா஡ஞ் சூளன஦றும் ச஬ட்ளட஦ண நனகும் 
            ஢ிள஧நசர்ந்஡ குன்஥ம் ஢ிளன஦ா – துள஧நசர் 
            அ஫ற்சி஬ினகும் அருந்஡ிற் கசப்தாங் 
            க஫ற்சி஦ிளன ச஦ன்றுள஧க்குங் கால். 
CHEMICAL CONSTITUTENTS: caesalpinianone,triterpenoids(1-4)alphaamyrin(1) 
ACTIONS : Antiperiodic, Tonic, Anthelmintic 




                                             ஓ஥ம் 
Botanical Name - Carum Copticum 
English Name – The Bishops weed 
Family –Apiaceae 
Used part - Seed 
சுக஬ –  கார்ப்பு 
஡ன்க஥ – ச஬ப்தம் 
திரிவு – கார்ப்பு  
           “சீ஡சு஧ங் காசஞ் சசரி஦ா஥ந் ஡ம்சதாரு஥ல் 
            நத஡ி஦ிள஧ச் சல்கடுப்பு நத஧ா஥ம் – ஏ஡ிரு஥ல்  
           தல்சனாடுதல் மூனம் தக஥ிள஬ந஢ா ச஦ன்சசம௃ந஥ா? 
            சசால்சசாடுநதாம் ஏம்ச஥ணச் சசால்”.  
CHEMICAL CONSTITUTENTS : Thymol, gamma-terpinene, p-cymenea 
ACTIONS : Tonic, Carminative, Stomachic 
PHARMACOLOGICAL ACTIVITES : Antiseptic, Carminative, Tonic 




Botanical Name - Acorus Calamus 
English Name – Sweet-flag 
Family – Acoraceae 
Used part - Rhizome 
சுக஬ –  கார்ப்பு 
஡ன்க஥ – ச஬ப்தம் 
திரிவு – கார்ப்பு  
           “தாம்தா஡ி ஢ஞ்சற் பு஡ப்புண் ஬னி஬ிடதாகங் குன்஥ம்  
            சூம்தா ரி஧த்஡தித் ஡ம்முக ஢ாற்நம்஬ன் சூளனசன்ணி 
            ஬மீ்தாம்ளத காசம் திலீகஞ் சினித஡ம் ஬நீிரு஥ல் 
            ஡ாம்தால் கிரு஥ி ஦ிள஬ந஦கு ஥ாசி஬ சம்திளணந஦”. 
CHEMICAL CONSTITUTENTS : alpha-asarone, beta-asarone, methylisoeugenol 
ACTIONS : Tonic, Antiperiodic, Disinfectant, Germicide 
PHARMACOLOGICAL ACTIVITES : Anti microbial, Anti oxidant, Insecticide. 




Botanical Name - Zingiber Officinale 
English Name – Dried Ginger 
Family – Zingiberaceae 
Used part - Rhizome  
சுக஬ – ளகப்பு, து஬ர்ப்பு, கார்ப்பு 
஡ன்க஥ – ச஬ப்தம் 
திரிவு – கார்ப்பு 
            “சூளன஥ந்஡ம் ச஢ஞ்சசரிப்பு ந஡ாடந஥ப் தம்஥஫ளன 
             மூனம் இள஧ப்திரு஥ல் மூக்கு஢ீர் – ஬ானகத 
            ந஡ாட஥஡ி சா஧ந் ச஡ாடர்஬ா஡ குன்஥஢ீர்த் 
            ந஡ாடம்ஆ ஥ம்நதாக்குஞ் சுக்கு”. 
 CHEMICAL CONSTITUTENTS : zingiberene  
ACTIONS : stimulant, stomachic, carminative 
PHARMACOLOGICAL ACTIVITES: Anti inflammatory, Anti microbial 




Botanical Name - Piper Nigrum 
English Name – Black pepper 
Family – Piperacea 
Used part - Fruit 
சுக஬ – ளகப்பு,  கார்ப்பு 
஡ன்க஥ – ச஬ப்தம் 
திரிவு – கார்ப்பு 
           “஡ீ஦ாகி ச஦ங்கும் ஡ிரிம௃஥ள஡ ஦ா஬த்து 
           ந஥ா஦ா஥ சனப்தடிம௃ முண்டாக்காற் – தா஦ாது 
           நதாந்஡ி஥ிர்஬ா ஡ங்கி஧ந்஡ி புண்஠ரீும் ஥ண்஠஬க்கும் 
           காந்஡ிச஥ய்஬ா ஡ச்சலுப்ளதக் காய்”.  
CHEMICAL CONSTITUTENTS : Piperine, Piperidine, Chavicine 
ACTIONS : Anti periodic, Antidote, Carminative, Stimulant 
PHARMACOLOGICAL ACTIVITES: Anti bacterial, Anti inflfammatory 




Botanical Name - Piper Longum 
English Name – Long Pepper 
Family – Pipeacea 
Used part - Fruit 
சுக஬ – ளகப்பு, து஬ர்ப்பு, கார்ப்பு 
஡ன்க஥ – ச஬ப்தம் 
திரிவு – இணிப்பு  
         “ஈளப ஦ிரு஥ல் னிள஧ப்பு தசப்தி஠ிகள் 
          ஥ாப ச஬ா஫ி஦ா஥ல் ஬ாட்டும் – ஦ால௃முளந 
          தாங்கா ஦நிந்து சசய்஬ரீ் தண்டி஡த்஡ப் தண்டி஡ந஧ 
          ந஬ங்ளக஬ாய் தான்களண ச஥ய்”. 
CHEMICAL CONSTITUTENTS : Piperine, Piperlongumine  
ACTIONS : Carminative, stimulant 
PHARMACOLOGICAL ACTIVITES : Anti bacterial 




Botanical Name - Phyla Nodiflora 
English Name – Purple lippie 
Family – Verbenaceae 
Used part - Fruit 
சுக஬ – ளகப்பு, து஬ர்ப்பு 
஡ன்க஥ – ச஬ப்தம் 
திரிவு – கார்ப்பு  
           “சதாடு஡ளன஦ின் நதருள஧த்஡ால் நதா஧ா஥ப் நதாக்கும் 
             அடு஡ளனசசய் காசம் அடங்கும் – கடுகி஬ரு 
             நத஡ிச஦ாடு சூளனந஢ாய் நதசரி஦ ச஬ண்ந஥கம் 
             ஬ா஡மும்நதா ச஥ய்ம௃஧க்கும் ஬ாழ்த்து”. 
CHEMICAL CONSTITUTENTS : Eupafolin, Tyrosinase  
ACTIONS :  Tonic, Expectorant, Astrigent 
PHARMACOLOGICAL ACTIVITES : Anti inflammatory, Antimicrobial. 
                   
 
 
PREPARATION OF TRIAL DRUG 
MANJANAATHI KUDINEER 
                                                                           Ref : Bala vagadam, Page No : 179 
INGREDIENTS : 
  Nuna ilai             – 1 pidi (70gram) 
  Notchi thulir       – 1 pidi (70gram) 
  Uthamani ilai      – 1 pidi (70gram) 
  Kazharchi ilai     – 1 pidi (70gram) 
  Omam                 – 1 varagan (4gram) 
  Vasambu             – 1 varagan (4gram) 
  Chukku               – 1 varagan (4gram) 
  Milagu                – 1 varagan (4gram) 
  Poduthalai kaai   – 1 varagan (4gram) 
  Thippili              –  1 varagan (4gram) 
 
METHOD OF PREPARATION : 
        The drugs are taken in the ratio mentioned above and are purified. Then they are 
grinded to the powder form and mixed with pure water and this mixture is boiled until the 
concentrated decotation of the ingredient is obtained. 
DOSE : 
     1 Sangalavu (8gram)- Twice a day daily 
(Preparation of kudineer : Add 8gram of chooranam to 60ml of water. Then boil the water 
till reaches to 8ml of kudineer). 
DURATION : 







   BIO- CHEMICAL 




 BIOCHEMICAL ANALYSIS OF MANJANAATHI KUDINEER 
PREPARATION OF EXTRACT 
              2gm of Manjanaathi kudineer sample is taken in 100ml beaker and 
20ml of distilled water is added. The solution is boiled for 10minutes, cooled 
and then filtered. The filtrate is called extract. 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1 




Test for chloride : 
2ml of extract is added with 
dilute Nitric acid till the 
effervescence ceases. Then 
2ml of silver nitrate solution 
is added 




Test for phosphate : 
2ml of extract is treated with 
2ml of Ammonium 
molybdate solution and 2ml 
of concentrated nitric acide. 




Test for carbonate : 
2ml of extract is treated with 
2ml of Magnesium sulphate 
solution 




Test for sulphide : 
1gm of the substance is 
treated with 2ml of 
concentrated Hydrochloric 
acid 




Test for sulphate : 
2ml of the above prepared 
extracts is taken in a test 
tube. To this add 2ml of 4% 
Ammonium oxalate solution. 










Test for copper : 
One pinch of substance is 
made into paste with 
concentrated Hydrochloric 
acid in a watch glass and 
introduced into the non-
luminous part of the flame. 
Absence of Bluish 
green coloured flame 
Absence 
B 
Test for iron : 
To the 2ml extract 2ml of 
Ammonium thiocyanate 
solution and 2ml of 
concentrated Nitric acid is 
added. 




Test for Zinc : 
To the 2ml of extract Sodium 
hydroxide solution is added 
in drops in excess. 




Test for calcium : 
To the 2ml of extract 
Ammonium oxalate solution 
is added. 




Test for magnesium : 
To the 2ml of extract Sodium 
hydroxide solution is added 





in drops in excess.  
 
F 
Test for starch : 
2ml of extracts treated with 
weak iodine solution 




Test for reducing sugar: 
5ml of Benedicts qualitative 
solution is taken in a test 
tube and allowed to boil for 
2minutes and added 10drops 
of the extract and again 
boiled for 2minutes. The 
colour changes are noted. 




Test for alkaloids : 
2ml of the extract is treated 
with 2ml of Potassium iodide 
solution. 




Test for ammonium : 
To the 2ml of extract few ml 
of Nessler‟s reagent and 
excess of Sodium hydroxide 
solution are added. 






   The given sample Manjanaathi Kudineer contains 
                      Acid Radical – Chloride 












ACUTE ORAL TOXICITY STUDY OF MANJANAATHI KUDINEER 
                                (OECD GUIDELINE – 423)     
 
Introduction: 
 The acute toxic class method is a stepwise procedure with the use of 3 animals of 
a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on average 
2-4 steps may be necessary to allow judgement on the acute toxicity of the test 
substance.  
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
 The acute toxic class method is based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification purposes 
and hazard assessment.  
 In principle, the method is not intended to allow the calculation of a precise LD50, 
but does allow for the determination of defined exposure ranges where lethality is 
expected since death of a proportion of the animals is still the major endpoint of 
this test.  
 The method allows for the determination of an LD50 value only when at least two 
doses result in mortality higher than 0% and lower than 100%.  
 The use of a selection of pre-defined doses, regardless of test substance, with   
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
 
Principle of the Test:  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. Absence 
or presence of compound-related mortality of the animals dosed at one step will 
determine the next step, i.e. 
− no further testing is needed 
− dosing of three additional animals, with the same dose  
− dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the test substance to 
one of a series of toxicity classes. 
 
Methodology: 
Selection of Animal Species  
 The preferred rodent species is the wistar albino rat, although other rodent species 
may be used. Healthy young adult animals are commonly used laboratory strains should 
be employed. Females should be nulliparous and non-pregnant. Each animal, at the 
commencement of its dosing, should be between 6 to 8 weeks old and the weight (150-
200gm) should fall in an interval within±20 % of the mean weight of any previously 
dosed animals.  
 
Housing and Feeding Conditions 
 The temperature in the experimental animal room should be 22ºC + 3ºC.  
Although the relative humidity should be at least 30% and preferably not exceed 70% 
other than during room cleaning the aim should be 50-60%. Lighting should be artificial, 
the sequence being 12 hours light, 12 hours dark. For feeding, conventional laboratory 
diets may be used with an unlimited supply of drinking water. Animals may be group-
caged by dose, but the number of animals per cage must not interfere with clear 
observations of each animal. 
 
Preparation of animals:   
The animals are randomly selected, marked to permit individual identification, and kept 
in their cages for at least 7 days prior to dosing to allow for acclimatization to the 
laboratory conditions 
Test Animals and Test Conditions:  
 Sexually mature Female Wistar albino rats (150-200gm) were obtained from 
TANUVAS, Madhavaram, Chennai. All the animals were kept under standard 
environmental condition (22±3°C).  The animals had free access to water and standard 
pellet diet (Sai meera foods, Bangalore). 
 
Preparation of animals:   
  The animals are randomly selected, marked to permit individual identification, and kept 
in their cages for at least 7 days prior to dosing to allow for acclimatization to the 
laboratory conditions 
Preparation for Acute Toxicity Studies 
 Rats were deprived of food overnight (but not water 16-18 h) prior to administration of 
the, MANJANAATHI KUDINEER.  
The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design 
 
IAEC approved  Number: 1248/AC/09/CPCSEA-9/DEC-2013/12  
 
Test Substance   : MANJANAATHI KUDINEER 
Animal Source   : TANUVAS,Madhavaram, Chennai.   
Animals    : Wister Albino Rats (Female-3+3) 
Age     : 6-8 weeks 
Body Weight on Day 0  : 150-200gm. 
Acclimatization   : Seven days prior to dosing. 
Veterinary examination  : Prior and at the end of the acclimatization period. 
Identification of animals  : By cage number, animal number and individual   
                 marking by using Picric acid.  
Number of animals                : 3 Female/group,  
Route of administration         : Oral  
 Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd,  
   Bangalore 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages   
                 provided with bedding of husk. 
Housing temperature :  between 22ºC + 3ºC.    
Relative humidity  :  between 30% and 70%, 
Air changes    : 10 to 15 per hour and  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 14 Days  
 
Administration of Doses:  
 MANJANAATHI KUDINEER was suspended in coconut water and administered 
to the groups of wistar albino rats in a single oral dose by gavage using a feeding needle. 
The control group received an equal volume of the vehicle. Animals were fasted 12 hours 
prior to dosing. Following the period of fasting, the animals were weighed and then the 
test substance was administered. Three Female animals are used for each group. The dose 
level of 5, 50, 300 and 2000 mg/kg body weight was administered stepwise. After the 
substance has been administered, food was withheld for a further 3-4 hours. The principle 
of laboratory animal care was followed. Observations were made and recorded 
systematically and continuously as per the guideline after substance administration. The 
visual observations included skin changes, mobility, aggressively, sensitivity to sound 
and pain, as well as respiratory movements. Finally, the number of survivors was noted 
after 24 hrs and these animals were then monitered for a further 14 days and observations 
made daily. The toxicological effect was assessed on the basis of mortality. 
 
Observations:  
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 
4 hours, and daily thereafter, for a total of 14 days, except where they need to be removed 
from the study and humanely killed for animal welfare reasons or are found dead. It 
should be determined by the toxic reactions, time of onset and length of recovery period, 
and may thus be extended when considered necessary. The times at which signs of 
toxicity appear and disappear are important, especially if there is a tendency for toxic 
signs to be delayed. All observations are systematically recorded with individual records 
being maintained for each animal. 
 
Observations include changes in skin and fur, eyes and mucous membranes, and 
also respiratory, circulatory, autonomic and central nervous systems, and somatomotor 
activity and behavior pattern. Attention was directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. The principles and criteria 
summarized in the Humane Endpoints Guidance Document taken into consideration. 
Animals found in a moribund condition and animals showing severe pain or enduring 
signs of severe distress was humanly killed. When animals are killed for human reasons 















Acute oral toxicity study of MANJANAATHI KUDINEER 









1 Body weight Normal 1 Body weight 
Normally increased 
 





Signs of Convulsion 
Limb paralysis 
Normal 3 
Signs of Convulsion 
Limb paralysis 
Absence of sign (-) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Absence 
6 Salivation Normal 6 Salivation Absence 
7 Change in skin color 
No significant color 
change 
7 Change in skin color No significant color change 
8 Piloerection Normal 8 Piloerection Normal 
9 Defecation Normal 
 
9 Defecation Normal 
 
10 Sensitivity response Normal 10 Sensitivity response Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 Muscle gripness Normal 
13 Rearing Mild 13 Rearing Mild 
14 Urination Normal 14 Urination Normal 
 
Behaviour: 
 The animals will be observed closely for behaviour in the first four hours which  
includes abnormal gait, aggressiveness, exophthalmos, ptosis, akinesia, catalepsy, 
convolusion, excitation, head twitches, lacrimation, loss of corneal reflex, loss of traction, 
piloerection  reactivity of touch, salivation, scratching, sedation, chewing,  head 
movements, sniffing, straub, tremor and writhes, diarrhea, leathery, sleep and coma.  
 
Body Weight:  
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed. 
 
Food and water Consumption: 




           Animals were observed for mortality throughout the entire period. 
 
Results: 
 All data were summarized in tabular form, (Table-1-4) showing for each test 
group the number of animals used, the number of animals displaying signs of toxicity, the 
number of animals found dead during the test, description of toxic symptoms, weight 
changes, food and water intake 










1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. Control + - - + - + - - - - - - - - - - - - - - 
2. 2000mg + - - + - + - - - - - - - - - - - - - - 
 
1..Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. 
Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. 

















1 7 14 
CONTROL 200.1±65.70 201.3 ± 41.11 201.6 ±02.12 
HIGH DOSE 202.3± 6.64 202.7 ±7.42 203.2 ± 2.70 
P value (p)* NS NS NS 





1 6 14 
CONTROL 64 ± 3.20 64±6.10 58.3±5.44 
HIGH DOSE 63.2±1.30 65.8±6.70 66.2±5.64 
P value (p)* NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett‟s test) 
 
Table 4: Food intake (gm/day) of Wistar albino rats group exposed to 





1 7 14 
CONTROL 86.03±2.42 87.2±2.46 89.7±8.16 

































The antimicrobial activity for test sample was done by Paper Disc Diffusion 
method. The sterilized (autoclaved at 120 
o
 C for 30 min ) medium ( 40-50 
o
 C ) was 
inoculated ( 1 ml / 100 ml of medium ) with the suspension ( 10 
5
 cfu mL 
-1
 ) of the 
microorganism ( matched to Mc Farland barium sulphate standard ) and poured in to a 
petridish to give depth of 3-4 mm. The paper impregnated with the test compound 
MANJANAATHI KUDINEER ( 25, 50, and 100 µg mL
-1
in dimethyl farmamide ) was 
placed on the solidified medium (Ashok Rathan, 2000). The plates were pre incubated 
for 1 h at room temperature and incubated at 37 degree Celsius for 24 and 48 h for anti 
bacterial activities respectively. Ciprofloxin was used as standard for anti bacterial 
respectively at the concentration of 50 mcg / disc. In-vitro antimicrobial activity of 
MANJANAATHI KUDINEER was screened against bacteria strains such as 
Streptococcus mutans, Staphylococcus aureus, Escherchia.coli, Klebsiella pneumoniae 
and Pseudomonas.aeruginosa. The test Sample concentration taken as 4ml – 400 ml of 
solvent in 10µl, 25 µl, 50 µl / disc. 
Antimicrobial activity: 
 
Table: 15. Antimicrobial activity of MANJANAATHI KUDINEER(MKR) 
 
 
Organism Standard drug Ciprofloxacin 50 mcg/disc 
Test drug ( µl/disc ) 
Zone of inhibition in mm 
10l 25l 50l 
Strep. mutans 32 24 36 38 
Staph. aureus 31 25 27 29 
E.coli 31 36 40 43 
K.pneumoniae 31 24 28 34 
P.aeruginosa 29 18 26 30 




1. Streptococcus mutans _ Highly sensitive in 10µl / disc 
2. Staphylococcus aureus _ Highly sensitive in 10µl / disc 
3. Escherchia.coli – Highly sensitive in 10µl / disc 
4. Klebsiella pneumoniae – Highly sensitive in 10µl / disc 
5. Pseudomonas aeruginosa _ Highly sensitive in  
 
10µl / disc Discussion: 
The anti microbial activity of MKR was compared with Standard drug 
Ciprofloxacin 50 mcg/disc for the following pathogens, they are Streptococcus mutans 
, Staphylococcus aureus , Escherchia.coli, Klebsiella pneumoniae and Pseudomonas 
aeruginosa. The results represents MKR potentially inhibit the growth of all above 
organism in 10µl, 25µl and 50µl / disc. The test drug results build known supports to 






























Project ID  NRS/AS/0342/02/2019 
Name and Address of the Researcher Dr.M.Hari Priya 
Government Siddha Medical College, Chennai 
Tamil Nadu, India 
Sample –ID Manjanaathi Kudineer Chooranam - MKC 
 
PHYTOCHEMICAL ANALYSIS 
Test for alkaloids: 
Mayer's Test: To the test sample, 2ml of mayer's reagent was added, a dull white 
precipitate revealed the presence of alkaloids. 
Test for coumarins:  
To the test sample, 1 ml of 10% sodium hydroxide was added. The presence of coumarins 
is indicated by the formation of yellow color. 
Test for saponins:  
To the test sample, 5 ml of water was added and the tube was shaken vigorously. Copious 
lather formation indicates the presence of Saponins. 
Test for tannins:  
 To the test sample, ferric chloride was added, formation of a dark blue or greenish black 
color showed the presence of tannins. 
Test for glycosides- Borntrager‟s Test 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on a water bath, 
filtered and the hydrolysate is subjected to the following tests. To 2 ml of filtered 
hydrolysate, 3 ml of choloroform is added and shaken, choloroform layer is separated and 
10% ammomia solution is added to it. Pink colour indicates presence of glycosides. 
 
 
Test for flavonoids: 
To the test sample about 5 ml of dilute ammonia solution were been added followed by 
addition of few drops of conc. Sulfuric acid. Appearance of yellow color indicates the 
presence of Flavonoids. 
Test for phenols: 
Lead acetate test: To the test sample; 3 ml of 10% lead acetate solution was added.  A 
bulky white precipitate indicated the presence of phenolic compounds. 
Test for steroids: 
To the test sample, 2ml of chloroform was added with few drops of conc. Sulphuric acid 
(3ml), and shaken well. The upper layer in the test tube was turns into red and sulphuric 
acid layer showed yellow with green fluorescence. It showed the presence of steroids. 
Triterpenoids  
Liebermann–Burchard test: To the chloroform solution, few drops of acetic 
anhydride was added then mixed well. 1 ml concentrated sulphuric acid was added from 
the sides of the test tube, appearance of red ring indicates the presence of triterpenoids. 
Test for Cyanins 
A. Aanthocyanin: 
       To the test sample, 1 ml of 2N sodium hydroxide was added and heated for 5 min at 
100ᵒC. Formation of bluish green colour indicates the presence of anthocyanin. 
Test for Carbohydrates - Benedict‟s test 
To the test sample about 0.5 ml of Benedic‟s reagent is added. The mixture is heated on a 
boiling water bath for 2 minutes. A characteristic coloured precipitate indicates the 
presence of sugar. 
Proteins (Biuret Test) 
To extracts 1% solution of copper sulphate was added followed by 5% solution of sodium 
hydroxide, formation of violet purple colour indicates the presence of proteins. 
Reference  






 Test Results for Alkaloids, Glycosides, Coumarins, Phenols and Tanins 
 
 

























 Physicochemical Evaluation 
Project ID  NRS/AS/0342/02/2019 
Name and Address of the Researcher Dr.M.Hari Priya 
Government Siddha Medical College, Chennai 
Tamil Nadu, India 
Sample –ID Manjanaathi Kudineer Chooranam - MKC 
 
Sample Description 
     
 
 
State Solid Decoction- Water Extraction 
Appearance Pale greenish Dark Reddish brown 
Nature Fibrous Coarse powder Viscous Liquid 





 Solubility Profile of MKC 
 
 
S.No Solvent Used Solubility / Dispersibility 
1 Chloroform Insoluble 
2 Ethanol Insoluble 
3 Water Soluble 
4 Ethyl acetate Sparingly soluble 
5 Hexane Insoluble 







Percentage Loss on Drying 
Test drug was accurately weighed in evaporating dish .The sample was dried at 
105
o
C for 5 hours and then weighed. 
Determination of Total Ash 
Test drug was accurately weighed in silica dish and incinerated at the furnace a 
temperature 400 ºC until it turns white in color which indicates absence of carbon. 
Percentage of total ash will be calculated with reference to the weight of air-dried drug. 
Determination of Acid Insoluble Ash 
The ash obtained by total ash test will be boiled with 25 ml of dilute hydrochloric 
acid for 6mins. Then the insoluble matter is collected in crucible and will be washed with 
hot water and ignited to constant weight. Percentage of acid insoluble ash will be 
calculated with reference to the weight of air-dried ash. 
Determination of Alcohol Soluble Extractive 
Test sample was macerated with 100 ml of Alcohol in a closed flask for twenty-
four hours, shaking frequently during six hours and allowing it to stand for eighteen 
hours. Filter rapidly, taking precautions against loss of solvent, evaporate 25 ml of the 
filtrate to dryness in a tared flat bottomed shallow dish, and dry at 105ºC, to constant 
weight and weigh. Calculate the percentage of alcohol-soluble extractive with reference 
to the air-dried drug. 
Determination of Water Soluble Extractive 
Test sample was macerated with 100 ml of water in a closed flask for twenty-four 
hours, shaking frequently during six hours and allowing it to stand and for eighteen hours. 
Filter rapidly, taking precautions against loss of solvent, evaporate 25 ml of the filtrate to 
dryness in a tared flat bottomed shallow dish, and dry at 105ºC, to constant weight and 







Final Test report MKC 
 
S.No Parameter Mean (n=3) SD 
1. Loss on Drying at 105 °C (%) 0.6333  ± 0.32 
2. Total Ash (%) 11.53  ± 1.858 
3. Acid insoluble Ash (%) 0.8267  ± 0.03 
5. Alcohol Soluble Extractive (%) 5.167  ± 0.75 




1. India Pharmacopeia I Volume I, Government of India, Ministry of Health and 
Family welfare, Indian Pharmacopeia commission, 2014. 
2. Pharmacopoeial Laboratory for Indian Medicine (PLIM) Guideline for 
standardization and evaluation of indian medicine which  include drugs of  
Ayurveda,  Unani and  Siddha systems. Department AYUSH .Ministry of Health 
























Test sample was subjected to thin layer chromatography (TLC) as per conventional one 
dimensional ascending method using silica gel 60F254, 7X6 cm (Merck) were cut with 
ordinary household scissors. Plate markings were made with soft pencil. Micro pipette 
were used to spot the sample for TLC applied sample volume 10-micro liter by using 
pipette at distance of 1 cm at 5 tracks. In the twin trough chamber with the specified 
solvent system After the run plates are dried and was observed using visible light Short-
wave UV light 254nm and light long-wave UV light 365 nm 
REFERENCE 
               Lukasz Komsta, Monika Waksmundzka-Hajnos, Joseph Sherma . Thin Layer 

















HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY ANALYSIS 
 
HPTLC method is a modern sophisticated and automated separation technique 
derived from TLC. Pre-coated HPTLC graded plates and auto sampler was used to 
achieve precision, sensitive, significant separation both qualitatively and quantitatively. 
High performance thin layer chromatography (HPTLC) is a valuable quality assessment 
tool for the evaluation of botanical materials efficiently and cost effectively. HPTLC 
method offers high degree of selectivity, sensitivity and rapidity combined with single-
step sample preparation. In addition it is a reliable method for the quantitation of nano 
grams level of samples. Thus this method can be conveniently adopted for routine quality 
control analysis. It provides chromatographic fingerprint of phytochemicals which is 
suitable for confirming the identity and purity of medicinal plant raw materials.  
 
Chromatogram Development 
It was carried out in CAMAG Twin Trough chambers. Sample elution was carried 
out according to the adsorption capability of the component to be analysed. After elution, 
plates were taken out of the chamber and dried. 
 
Scanning 
Plates were scanned under UV at 366nm. The data obtained from scanning were 
brought into integration through CAMAG software. Chromatographic finger print was 




1. Wagner H. Plant Drug Analysis. A thin Layer chromatography Atlas.2nd ed. 












               Test Report 
Test for Specific Pathogen 
Methodology 
One part of the test sample was dissolved in 9 mL of sterile distilled water and the test 
sample was directly inoculated in to the specific pathogen medium (EMB, DCC, Mannitol 
,Cetrimide) by pour plate method. The plates were incubated at 37
o
C for 24 - 72h for observation. 
Presence of specific pathogen identified by their characteristic color with respect to pattern of 
colony formation in each differential media. 
 
Detail of Specific Medium and their abbreviation 
Organism Abbreviation Medium  
E-coli EC EMB Agar 
Salmonella SA Deoxycholate agar 
Staphylococcus Aureus ST Mannitol salt agar 
Pseudomonas Aeruginosa PS Cetrimide Agar 
 
Observation 
No growth was observed after incubation period. Reveals the absence of specific 
pathogen 
Result 
No growth / colonies were observed in any of the plates inoculated with the test sample. 
 
Organism Specification Result Method 
E-coli Absent Absent  
As per AYUSH 
specification 
Salmonella Absent Absent 
Staphylococcus Aureus Absent Absent 







Culture plate with E-coli (EC) specific medium  
 
      
 
            
Culture plate with Salmonella (SA) specific medium 






Culture plate with Staphylococcus Aureus (ST) specific mediu    
   
   
 
 
Culture plate with Pseudomonas Aeruginosa (PS) specific medium 
 












STERILITY TEST BY POUR PLATE METHOD 
Objective  
        The pour plate techniques were adopted to determine the sterility of the product. 
Contaminated / un sterile sample (formulation) when come in contact with the nutrition rich 
medium it promotes the growth of the organism and after stipulated period of incubation the 
growth of the organism was identified by characteristic pattern of colonies. The colonies are 
referred to as Colony Forming Units (CFUs).   
Methodology 
        Test sample was admixed with sterile distilled water and the mixture were been used for the 
sterility evaluation. About 1ml of the test sample was inoculated in sterile petri dish to which 
about 15 mL of molten agar 45
o
C were added. Agar and sample were mixed thoroughly by tilting 
and swirling the dish. Agar was allowed to completely gel without disturbing it. (about 10 
minutes). Plates were then inverted and incubated at 37
o
 C for 24-48 hours. Grown colonies of 
organism was then counted and calculated for CFU.  
           
              
Observation 
No growth was observed after incubation period. Reveals the absence of specific 
pathogen 
Result 
No growth / colonies were observed in any of the plates inoculates with the test sample. 
Test Result Specification As per AYUSH/WHO 
Total Bacterial Count Absent NMT 10
5
CFU/g As per AYUSH 
specification 



















Std. Deviation 77.14 




Microscopic observation of the particle size analysis reveals that the average particle size of the 
sample was found to be 386.13  ± 77.14 µm  
Reference 
1.Morgan AJ. X-ray microanalysis in electron microscopy for biologists. Oxford University Press; 
1985 
2.Takashi Hiroi. Measurement of Particle Size Distribution in Turbid Solutions by Dynamic Light 

























































MATERIALS AND METHODS 
CLINICAL STUDIES :  
            After finishing the toxicity studies 40 paediatric cases were selected on the basis 
of inclusion criteria from the OPD of Kuzhanthai Maruthuvam Department, Arignar Anna 
Govt. Hospital, Chennai. They were treated with the trial drug Manjanaathi Kudineer 
and observed for prognosis clinically. 
STUDY DESIGN  
           A clinical trial on Neer kana Maantham was carried out in the Post Graduate 
Department of Kuzhanthai Maruthuvam in Govt.Siddha Medical College attached to 
Arignar Anna Hospital of Indian Medicine, Chennai-106 during the period of 2018-19. 
         The study was approved by Institutional Ethics Committee (IEC) and the approval 
number is IEC No : GSMC-CH-ME-2/016/2017 
SAMPLE SIZE :  
        The study is conducted in 40 selected patients of both genders between age groups of 
2-12Years. 
INCLUSION CRITERIA : 
       Age 2-12years 
       Running nose 
       Cough 
       Fever 
       Malaise 
       Diarrhea 




EXCLUSION CRITERIA  
      Allergic Rhinitis 
      Bronchitis 
      Bronchial Asthma 
      Severe Diarrhea with other complications.  
WITH DRAWAL CRITERIA : 
      Exacerbation of the symptoms 
     Occurrence of any adverse effects 
     Patients turned unwilling during follow up. 
ASSESSMENTS AND INVESTIGATIONS : 





o Loss of appetite 







o Naadi  
o Moothiram-Neer Kuri, Nei Kuri 
ROUTINE TESTS AND INVESTIGATIONS 
Blood        : TC, DC, ESR ,Hb. 
Urine         : Albumin, Sugar, Deposits. 
METHODOLOGY OF TREATMENT 
Study Enrolment: 
 Patient reporting at the OPD associated with clinical features of Running nose, 
cough, fever, malaise, fatigue are chosen for enrolment based on the inclusion criteria. 
The patients who are enrolled are informed about the study trial drug, possible outcomes 
and the objectives of the study in the language and terms understandable to them and then 
informed consent/assent would be obtained from the patient/patient‟s parent using 
Consent/Assent form. 
Conduct of the Study: 
 The trial drug will be given in the OPD of  P.G. Kuzhanthai Maruthuvam, GSMC, 
Chennai. The patients will be asked to have a regular follow up in the OPD once in 3days. 
In each and every visit the clinical assessment will be recorded in the prescribed 
proforma. The laboratory investigations will be done before and after treatment and 
recorded in the  prescribed format. 
DATA COLLECTION FORMS:  
 Required information will be collected from each patient by using following 
forms 
Form I      :  Screening and selection proforma. 
Form II     :  History taking proforma. 
Form III    : Clinical assessment proforma. 
Form IV    : Clinical assessment during and after trial. 
Form V     : Laboratory Investigation proforma. 
Form VI    : Informed Consent/Assent form. 
Form VII   : Withdrawal form. 
Form VIII :  Patient information sheet. 
DATA ANALYSIS: 
After enrolling the patients in the study, a separate file for each patient will be 
maintained and all forms will be kept in the file. Whenever the patient visits OPD during 
the study period, necessary entries will be made in the assessment forms. 
The data entries and adverse events if any will be monitored by the Head of the 
Department. 
OUTCOME OF TREATMENT: 
Primary Outcome: 
 Primary outcome is mainly assessed by comparing the reduction in clinical 
symptoms and recurrence before and after treatment. 
Secondary Outcome: 
 Secondary outcome is assessed by comparing the safety parameters before and 
after treatment. 
ADVERSE EFFECT AND SERIOUS EFFECT MANAGEMENT: 
 If the trial patient develops any adverse reactions, the patient will be referred to 
the Pharmacovigilance department of SCRI and documented for any adverse effect and 
then the investigator will be giving proper management for the adverse reaction  in the 
OPD. 
 
ETHICAL ISSUES:                                                                                                                                  
1. Informed Consent/Assent will be obtained from the patient/patient‟s parent 
or guardian after explaining about the clinical trial in an understandable 
language. 
2. After the Consent/Assent of the patient or patient‟s parent (through 
Consent/Assent) if they fit in the criteria, they will be enrolled in the study. 
3. Treatment will be provided free of cost. 
4. Concomitant medicines will be used if there is any need. 
5. The patients who are excluded (as per the exclusion criteria) will be 




























RESULTS AND OBSERVATIONS 
             A total number of 40 child patients with signs and symptoms of Neer Kana 
Maantham attending PG-IV, Kuzhanthai Maruthuvam Out Patient Department in Govt. 
Siddha Medical College attached to Arignar Anna Hospital were observed in the present 
study. The observation were made and tabulated with regards to the following features : 
1. Age Distribution 
2. Gender Distribution 
3. Family History 
4. Diet History 
5. Socio-Economic status 
6. Uyirthathukkal 
7. Udarthathukkal 














1. AGE DISTRIBUTION 
S.NO AGE No.of Cases (Out of 40) Percentage 
1 2-3years 7 17.5% 
2 4-6years 17 42.5% 
3 7-10years 14 35% 





The above table indicates that children coming under 2-3years of age group were 17.5%, 




 2.GENDER DISTRIBUTION 
GENDER NO.OF PATIENTS PERCENTAGE 
MALE 27 67.5% 





  Among 40 cases for this study, 27 children – 67.5% were male child and 13 children – 





 3.FAMILY HISTORY 
S.NO FAMILY HISTORY 
NO.OF CASES 
(OUT OF 40) 
PERCENTAGE 
1 Positive 6 15% 








 4.DIET HISTORY 
DIETARY HABITS NO.OF CASES(OUT OF 40) PERCENTAGE 
Vegetarian 5 12.5% 











S.NO STATUS NO.OF CASES(OUT OF 40) PERCENTAGE 
1 Rich 4 10% 
2 Middle 15 37.5% 





Out of 40 cases, 4 cases were rich – 10% in status, 15 cases were middle -37.5% in status 





    1.Vatham 
S.NO VATHAM NO.OF CASES(OUT OF 40) PERCENTAGE 
1 Praanan - - 
2 Abaanan - - 
3 Vyanan 4 10% 
4 Udhanan 40 100% 
5 Samaanan 15 37.5% 
6 Naagan - - 
7 Koorman - - 
8 Kirukaran 40 100% 
9 Devadhathan - - 




 In vatham, Vyanan was affected in 4 cases ie 10%, Udhanan was affected in 40 cases ie 




S.NO PITHAM NO.OF CASES(OUT OF 40) PERCENTAGE 
1 Anal Pitham 33 82.5% 
2 Ranjaga Pitham 8 20% 
3 Saathaga Pitham 9 22.5% 
4 Prasaga Pitham - - 





  In pitham, Anal pitham was affected in 33cases ie 82.5% , Ranjaka pitham was affected 
in 8 cases ie 20% and Saathaga Pitham was affected in 9 cases ie 22.5% 
 
 3.Kabam 
S.NO KABAM NO.OF CASES(OUT OF 40) PERCENTAGE 
1 Avalambakam 40 100% 
2 Kilethakam 10 25% 
3 Pothakam - - 
4 Tharpakam - - 




In kabam, Avalambakam was affected in 10 cases ie 100% and Kilethakam was affected 




(OUT OF 40) 
PERCENTAGE 
1 Saaram 40 100% 
2 Senneer 8 20% 
3 Oon - - 
4 Kozhuppu - - 
5 Enbu - - 
6 Moolai - - 




 In udharthathukkal, Saaram was affected in 40 cases ie 100% and Senneer was affected 









(OUT OF 40) 
 
PERECENTAGE 
1 Naa 11 27.5% 
2 Niram 7 17.5% 
3 Mozhi - - 
4 Vizhi 7 17.5% 
5 Sparism 10 25% 
6 Malam - - 
















Inference :  
In envagai thervugal, Naa affected in 27.5% cases, Niram and Vizhi was affected in 
17.5% cases, Sparism was affected in 25% cases. In case of Naadi Vathapitham was seen 
in 15 cases ie 37.5%, Vathakabam was seen in 12 cases ie 30% and Pithakabam was seen 
in 13 cases ie 32.5% respectively. 
9.NILAM 
S.NO NILAM NO.OF CASES (OUT OF 40) PERCENTAGE 
1 Kurinji - - 
2 Mullai - - 
3 Marudham - - 
4 Neithal 40 100% 









10. PARUVA KAALAM 
S.NO PARUVAKAALAM NO.OF CASES (OUT OF 40) PERCENTAGE 
1 Kaarkaalam 4 10% 
2 Koothirkaalam 8 20% 
3 Munpanikaalam 26 65% 
4 Pinpanikaalam 2 5% 
5 Elavenilkaalam 0 0% 




The more prevalence of the disease is under Munpanikaalam – 65%. 20% of children 
were affected in Koothirkaalam, 10% of children were affected in Kaarkaalam and 5% 





S.NO NEIKKURI NO.OF CASES (OUT OF 40) PERCENTAGE 
1 Vathaneer 28 70% 
2 Pithaneer 10 25% 




Among 40 cases, vathaneer was observed in 70% of cases, pithaneer was observed in 





















1 Cough 40 100% 3 7.5% 
2 Running Nose 40 100% 5 12.5% 
3 Fever 6 15% 1 2.5% 
4 Malaise 4 10% 1 2.5% 




The above table reveals that, among 40 cases, 100% had cough before treatment and was 
reduced to 7.5%, 100% cases had running nose before treatment and was reduced to 
17.5%. 15% cases had fever before treatment and was reduced to 2.5%, 10% cases had 
malaise before treatment and was reduced to 2.5% after treatment. 
13.RESULTS OF NEER KANA MAANTHAM 
S.NO PROGNOSIS NO.OF CASES (OUT OF 40) PERCENTAGE 
1 Good 33 82.5% 
2 Moderate 5 12.5% 




 Among 40 cases, 33 cases ie 82.5% showed good prognosis, 5 cases ie 12.5% showed 















1.  4660 PREM 21/2yrs/ MC 11 Good 
2.  4687 BASHA 3yrs / MC 9 Good 
3.  9036 DHANIYA 5yrs / FC 9 Good 
4.  9076 JANANI 5yrs / FC 8 Moderate 
5.  2554 MANGALYA 6yrs / FC 10 Good 
6.  3749 AJAY 9yrs / MC 11 Good 
7.  3802 DHANVANTHIRAN 4yrs / MC 8 Good 
8.  3816 MAITHRAIYAN 6yrs / MC 8 Good 
9.  8563 VISHAL 9yrs / MC 9 Moderate 
10.  2086 SARVESH 41/2yrs/ MC 9 Good 
11.  2035 THANISH 21/2yrs/ MC 11 Good 
12.  2920 MAZHI ANBU 21/2yrs/ MC 5 Moderate 
13.  4430 KAKHAN 5yrs / MC 10 Good 
14.  4741 AJAY 11yrs / MC 7 Good 
15.  4742 NAKSHATRA 8yrs / FC 6 Poor 
16.  4722 IRSHANTH 21/2yrs/ MC 10 Moderate 
17.  5327 NIRASH 41/2yrs/ MC 6 Good 
18.  5480 ABISHEK 8yrs / MC 6 Good 
19.  6049 KAYAL 4yrs / FC 6 Moderate 
20.  6758 
FATHUMUTHUZOHA
RE 





  21.              7248 DEEPIKA 8yrs /  FC     11    Good 
  22.  7290 HARISH 
MAIYAPPAN 
31/2yrs/ MC       7    Good 
  23.  7247 MITHILESH SAI 31/2yrs/ MC       8    Good 
  24.  7502 MANIMARAN 6yrs / MC       6    Good 
  25.  7686 SAISARAN 4yrs / MC       5    Good 
  26.  4774 SRIMATHI 10yrs / FC       5    Good 
  27.  6353 JOSHIKA 5yrs / FC       6    Good 
  28.  7574 SHYAM 8yrs / MC     10    Good 
  29.  7706 ALIYAN 6yrs / MC     10    Good 
  30.  8248 SRINITHI 6yrs / FC       5    Good 
  31.  9070 BHUVANESH 3yrs / MC       8    Good 
  32.  9140 DHARANI 9yrs / FC       8    Good 
  33.  8999 LOHITH 8yrs / MC       9    Good 
  34.  393 SAIKRISH 3yrs / MC     10    Good 
  35.  392 THARUN RAM 7yrs / MC       8    Good 
  36.  1513 RANJITH 31/2yrs/ MC       7    Good 
  37.  1640 NAKSHATHIRA 8yrs / FC     10    Good 
  38.  2912 DHANALAKSHMI 7yrs / FC       6     Poor 
  39.  6264 JAGATHRAJ 9yrs / MC       6    Good 
























                     




            URINE ANALYSIS 
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1 4660 PREM 21/2yrs/MC 7500 44 48 8 15 26 8600 52 45 3 10 20 12.1 12.2 Nil Nil Nil Nil Nil Nil 
2 4687 BASHA 3yrs/MC 13100 43 51 6 14 20 10900 49 47 4 7 15 11.8 12 Nil Nil Nil Nil Nil Nil 
3 9036 DHANIYA 5yrs/FC 9400 49 45 6 6 15 9600 50 47 3 4 9 11.6 11.8 Nil Nil Nil Nil Nil Nil 
4 9076 JANANI 5yrs/FC 6800 73 24 3 21 38 7500 75 23 2 15 23 10.7 11 Nil Nil Nil Nil Nil Nil 
5 2554 MANGALYA 6yrs/FC 7500 48 45 7 14 20 7900 49 47 4 5 10 11 11.2 Nil Nil Nil Nil Nil Nil 
6 3749 AJAY 9yrs/MC 9500 61 31 8 13 22 10300 63 32 5 8 14 12.4 13 Nil Nil Nil Nil Nil Nil 
7 3802 DHANVANTHIRAN 4yrs/MC 8400 46 47 7 8 15 9200 48 48 4 5 10 14.4 14.6 Nil Nil Nil Nil Nil Nil 
8 3816 MAITHRAIYAN 6yrs/MC 8200 52 42 6 5 12 8900 53 44 3 2 5 9.3 10 Nil Nil Nil Nil Nil Nil 
9 8563 VISHAL 9yrs/MC 12500 60 33 7 20 38 13100 61 34 5 15 32 11.9 12.1 Nil Nil Nil Nil Nil Nil 
10 2086 SARVESH 41/2yrs/MC 8900 44 48 8 14 22 9200 47 49 4 10 17 11.3 11.7 Nil Nil Nil Nil Nil Nil 
11 2035 THANISH 21/2yrs/MC 8500 41 49 10 10 22 8900 42 51 7 7 16 11.5 11.8 Nil Nil Nil Nil Nil Nil 
12 2920 MAZHI ANBU 21/2yrs/MC 16100 69 25 6 30 59 10900 71 25 4 19 39 11.5 11.9 Nil Nil Nil Nil Nil Nil 
13 4430 KAKHAN 5yrs/MC 12500 77 17 6 3 5 11900 79 18 3 2 4 11.6 11.8 Nil Nil Nil Nil Nil Nil 
14 4741 AJAY 11yrs/MC 8500 47 46 7 15 24 8900 50 46 4 8 16 13.5 13.6 Nil  Nil Nil Nil Nil Nil 
15 4742 NAKSHATRA 8yrs/FC 9900 56 36 8 25 58 10000 58 38 4 18 45 12.6 12.7 Nil Nil Nil Nil Nil Nil 
16 4722 IRSHANTH 21/2yrs/MC 8900 47 45 8 18 38 9200 48 46 6 14 32 9 9.2 Nil Nil Nil Nil Nil Nil 
17 5327 NIRASH 41/2yrs/MC 15500 54 37 9 12 25 8400 52 41 7 4 10 8.8 8.9 Nil Nil Nil Nil Nil Nil 
18 5480 ABISHEK 8yrs/MC 9000 49 42 9 7 12 9900 51 44 5 4 9 12 12.4 Nil Nil Nil Nil Nil Nil 
19 6049 KAYAL 4yrs/FC 9600 48 43 9 22 36 9900 51 44 5 14 22 9.2 9.4 Nil Nil Nil Nil Nil Nil 
20 6758 FATHUMUTHUZOH
ARE 
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21 7248 DEEPIKA 8yrs/FC 16300 76 19 5 10 19 12300 77 20 3 6 13 13 13.6 Nil Nil Nil Nil Nil Nil 




10300 72 23 5 7 15 10500 73 24 3 3 10 11.4 11.8 Nil Nil Nil Nil Nil Nil 
23 7247 MITHILESH SAI 31/2yrs/M
C 
8600 62 29 9 6 10 9300 63 33 4 3 7 11.8 12.1 Nil Nil Nil Nil Nil Nil 
24 7502 MANIMARAN 6yrs/MC 6900 40 51 9 5 15 8100 44 52 4 2 12 10.5 10.9 Nil Nil Nil Nil Nil Nil 
25 7686 SAISARAN 4yrs/MC 7400 42 51 7 7 15 8200 53 43 4 4 12 11.4 11.8 Nil Nil Nil Nil Nil Nil 
26 4774 SRIMATHI 10yrs/FC 8600 62 3 7 5 15 8500 58 39 3 3 9 13 13.1 Nil Nil Nil Nil Nil Nil 
27 6353 JOSHIKA 5yrs/FC 10000 57 38 5 13 20 9800 58 39 3 6 13 12.4 12.6 Nil Nil Nil Nil Nil Nil 
28 7574 SHYAM 8yrs/MC 7200 64 30 6 5 12 8100 66 30 4 3 9 10.2 10.6 Nil Nil Nil Nil Nil Nil 
29 7706 ALIYAN 6yrs/MC 9500 68 26 6 10 22 9800 69 27 4 6 15 11 11.4 Nil Nil Nil Nil Nil Nil 
30 8248 SRINITHI 6yrs/FC 13100 65 30 5 10 25 12400 67 30 3 5 18 12.5 12.8 Nil Nil Nil Nil Nil Nil 
31 9070 BHUVANESH 3yrs/MC 4600 61 34 5 7 14 6300 62 35 3 4 9 11.9 12.1 Nil Nil Nil Nil Nil Nil 
32 9140 DHARANI 9yrs/FC 8000 40 53 7 3 5 8600 51 45 4 2 4 11.6 11.8 Nil Nil Nil Nil Nil Nil 
33 8999 LOHITH 8yrs/MC 10000 58 36 6 9 15 9800 59 37 4 4 8 13 13.2 Nil Nil Nil Nil Nil Nil 
34 393 SAIKRISH 3yrs/MC 11200 37 56 7 2 10 10800 58 38 4 2 5 11.4 11.8 Nil Nil Nil Nil Nil Nil 
35 392 THARUN RAM 7yrs/MC 15300 71 23 6 12 22 10900 69 28 3 5 16 12.1 12.4 Nil Nil Nil Nil Nil Nil 
36 1513 RANJITH 31/2yrs/M
C 
5800 58 35 7 7 15 7200 59 36 5 4 9 11.6 11.8 Nil Nil Nil Nil Nil Nil 
37 1640 NAKSHATHIRA 8yrS/FC 6500 60 32 8 5 12 7300 62 34 4 3 8 12 12.4 Nil Nil Nil Nil Nil Nil 
38 2912 DHANALAKSHMI 7yrs/FC 5700 48 45 7 25 58 6300 50 46 4 12 40 10.6 10.8 Nil Nil Nil Nil Nil Nil 
39 6264 JAGATHRAJ 9yrs/MC 5200 47 45 8 3 5 6800 50 46 4 2 4 12.3 12.8 Nil Nil Nil Nil Nil Nil 






















                     
                                          DISCUSSION 
        Neer kana maantham is a most common, repeated disease of the children mainly 
affecting the upper respiratory tract with or without inflammation. The disease is 
characterized by cough, running nose, fever, malaise, diarrhea and lack of appetite. 
      In this study, 40 cases were selected according to the proforma with undergone 
investigation and treated with the trail drug MANJANAATHI KUDINEER for 7days 
with after treatment investigation in the OPD of PG-Dept of Kuzhanthai Maruthuvam, 
Govt.Siddha Medical College attached to Arignar Anna Hospital of Indian Medicine, 
Chennai-106. The data were collected and prognosis of the disease with the trial drug 
was clearly observed. 
                 This study evaluate the effect of “MANJANAAATHI KUDINEER ” on 
NEER KANA MAANTHAM (ACUTE NASO PHARYNGITIS). 
The observation are described here 
1.Age distribution 
     According to children age under 2-3years of age group were 17.5%, 4-6years were 
42.5%, 7-10years of age group were 35%, 11-12years of age were 5% respectively. 
Hence this study reveals that Neer Kana Maantham was prevailed more in 4-6years 
children. 
2. Gender distribution 
      Among the cases for this study, 27(67.5%) children were male and 13(32.5%) 





    According to family history, 6(15%) cases were reported positive family history and 
34(85%) cases have negative family history. Hence family history may impact on Neer 
Kana Maantham. 
4.Diet History  
   According to 40 patients 5(12.5%) were vegetarians and 35(87.5%) were noon-
vegetarians. 
5.Socio-Economic status  
   Regarding socio-economic status, 21(52.5%) cases were belong to poor status, 
15(37.5%) cases were belong to middle class and 4(10%) cases belong to high class.  The 
highest incidence was observed in poor class children due to poor hygiene. 
6.Uyir Thathukkal 
  Disturbance of Vatham  
       In 40 cases, among 10types of Vatham, Vyanan, Udhanan, Samanan and Kirukaran 
are affected. Udhanan and Kirukaran are affected in 40(100%) of cases, Vyanan is 
affected in 4(10%) of cases and Samanan is affected in 15(37.5%) of cases. 
Disturbance of Pitham  
     In 40 cases, among 5types of Pitham, Anal pitham is affected in 33(82.5%)of cases, 
Ranjaga pitham is affected in 8(20%) of cases and Sathaga pitham is affected in 9(22.5%) 
of cases. 
Disturbance of Kabam 
     In 40 cases, among 5types of Kabam, Avalambakam is affected in 40(100%) of cases 
and Klethakam is affected in 10(25%) of cases.  
 
7.Udarthathukkal 
In Udarthathukkal, Saaram was affected in 40(100%) of cases and Senneer was affected 
in 8 (20%) of cases. 
8.Ennvagai Thervugal 
Among 40 cases, Naa is affected in 11(27.5%) of cases, Niram is affected in 7(17.5%) of 
cases, Vizhi is affected in 7(17.5%)of cases, Sparism is affected in 10(25%) of cases and 
Naadi is felt among 40 cases were Vathapitham in 15(37.5%) cases, Vathakabam in 
12(30%) cases and Pithakabam in13(32.5%) cases. 
9.Nei kkuri 
Among 40 cases, Vatha veer was observed in 28(70%) cases, Pitha neer was observed in 
10(25%) cases, Kaba neer was observed in 2(5%) cases. 
10.According to Paruvakaalam 
Regarding Paruvakaalam among 40 cases, 4(10%) cases were reported in Kaarkalam, 
8(20%) cases were reported in Koothir kaalam,0 cases were reported in Elavenil kaalam, 
26(65%) cases were reported in Munpani kaalam, 2(5%) cases were reported in Pinpani 
kaalam and 0 cases were reported in Muduvenil kaalam respectively. 
11.Distribution of Nilam 
All the 40 cases reported were from surroundings of Chennai which belongs to Neithal 
nilam. 
12.Clinical Presentation 
Out of 40 patients, before treatment all the 40 patients (100%) had cough, 40(100%) had 
running nose, 6(15%) had fever and 4(10%) had malaise. After treatment most of the 
patients were relieved from the symptoms of cough, fever, running nose and malaise. 
Improvement in appetite is increased din most of the cases additionally. 
13.Phytochemical analysis 
The phytochemical analysis of the trial drug shows that the drug contains alkaloids, 
flavonoids, carbohydrates, iron, chloride, tri terpenoids, phenol, glycosides, tannins and 
protein. 
14.Toxicity study of the drug 
Acute toxicity study of the trial drug was carried out in Wistar Albino rat‟s reveals that 
the drug has no adverse effects, so it is safe for human beings. 
15.Physicochemical analysis 
Ash value – 11.53% 
16. Bio Chemical Analysis 
Bio chemical analysis of the drug showed the presence of chloride, iron and zinc. 
17.Pharmacological analysis 
Pharmacological analysis showed the drug has convincing Anti-microbial activity against 
the gram positive bacteria, gram negative bacteria. 
18.Statistical Analysis 
The preclinical studies of the trial medicine statistically analyzed and showed significant 
result. 
19.Results 
The outcome of this study showed encouraging results. Among the 40 patients good 
improvement was observed in 33(82.5%)cases, moderate improvement was observed in 
5(12.5%)cases and mild improvement in 2(5%)cases and no adverse events observed 


















          The disease Neer Kana Maantham was taken for the clinical study with 
Manjanaathi Kudineer as internal medicine. For the clinical study, 40 patients were 
selected based on Inclusion and Exclusion criteria. The study is conducted after the drug 
being screened by the Screening Committee and the trial is also approved by the 
Institutional Ethical Committee (IEC). Animal studies are carried out after obtaining 
proper permission from the Institutional Animal Ethical Committee (IAEC). Hence the 
study is safely executed on human volunteer patients and there was no adverse drug 
reactions noted during the study period. 40 children with Neer Kana Maantham diagnosed 
clinically treated in out patient department of Arignar Anna Hospital of Indian Medicine, 
Chennai-106. They were observed for clinical improvement, laboratory investigation 
done and treated with trial drug. 
I like to summarize this study with the following highlights. 
 The efficacies of the trial drug Manjanaathi Kudineer were studies and observed 
in this study. 
 Clinical diagnosis of Neer Kana Maantham was done on the basis of clinical 
features described in Bala Vagadam . 
 The cost of the trial medicines are low, comparatively economic. 
These drugs are easily available and the dosage is also convenient. 
 The potency of the trial drug were studied by phytochemical analysis, physic 
chemical analysis and pharmacological analysis. 
Phytochemical analysis of the trial drug reveals that the presence of alkaloids, flavonoids, 
carbohydrates, iron, chloride, tri terpenoids, phenol, glycosides, tannins and protein. 
 The physico chemical analysis of the trial drug shows the Ash value 11.53. So it 
shows the safety and effectiveness of the drug. 
 The pharmacological analysis of the drug reveals that it possesses convincing 
Anti-microbial property. 
 Among the 40 cases treated 33 cases(82.5%) had shown Good improvement, 
5cases(12.5%) had shown Moderate improvement, 2cases(5%) had shown Mild 
improvement. 
 Observation made during the clinical study showed that the trial drug was 


































                 Neer Kana Maantham is a common disease in children and mainly 
caused by derangement of the Kaba kuttram. In this clinical study Manjanaathi 
Kudineer was taken as Internal medicnine respectively. The deranged kabam is 
settled down by the kaarppu suvai in the trial medicine there by the medicine 
acts as Ethirurai maruthuvam to cure the disease. Toxicological studies showed 
no acute toxicity. The drug has got Anti-microbial activity. The cost of the trial 
medicine are low. During the clinical study no adverse events were observed. 
             The clinical study confirms the efficacy of the trial drugs by reducing 
the clinical signs and symptoms like cough, cold, running nose, fever and loss 
of appetite. Clinical study results found to be Good in 33cases(82.5%), 
Moderate in 5 cases(12.5%) and Mild in 2 cases (5%). The clinical trial 
conducted in selected patients was satisfactory and encouraging. The trial 
medicine is effective for Neer Kana Maantham in children. Through this study, 
the effectiveness of trial drug is confirmed and re-established by the author and 
concluded that the trial drug “Manjanaathi Kuineer” is effective in treatment 



























                                     
                                   BIO STATICAL ANALYSIS 
 
Treatment for Neer Kana Maantham(Acute Naso Pharyngitis) 
              The most popular non parametric statistical tool, namely, McNemer Test analysis 
has been employed to analyze the effectiveness with the help of hypothesis. 
S.NO Clinical Features Before Treatment After treatment 
            n%           n% 
   1    Cough       40(100)        3(7.5)* 
   2    Running nose       40(100)       5(12.5)** 
   3    Fever         6(15)       1(2.5)*** 
   4   Malaise         4(10)       1(2.5)*** 
   5   Diarrhea           0             0 
 
McNemar‟s test : C.I:95% *P*<0.001 **P= 0.063   ***P<0.2500 
Software : spss 16 version 
Number of cases : 40 
Inference :  
         Since the p value is significant in all signs and symptoms. So there is significant 
reducing of signs and symptoms among the patients for the treatment of Neer Kana 















































GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “MANJANAATHI KUDINEER CHOORNAM” IN THE 
TREATMENT OF 
“NEER KANA MAANTHAM‟‟ (ACUTE NASOPHARYNGITIS) IN CHILDREN 
FORM l - SCREENING AND SELECTION PROFORMA 
1. OP NO :  ............................................................................ 
2. NAME :  …………………………………………...........  
3. AGE :      ………        4.GENDER :  …………....... 
5. F.OCCUPATION : ……………………       6.F.INCOME:   ………………… 
7. ADDRESS :    …………………………………….............    
            ……………………………………............ 
            ……………………………………........... 
8. CONTACT NO :   ……………………………………              
 INCLUSION CRITERIA: 
 Age :  2-12 Years                 Yes/ No 
 Running Nose                                                                              Yes/ No    
 Cough                                                                                          Yes/ No 
 Fever                                                                                            Yes/ No 
 Malaise                                                                                         Yes/ No 
 Diarrhea                                                                                        Yes/No 
 Patients who are willing to undergo Laboratory investigation.   Yes/No  
 Patients who are willing to sign the informed consent stating that he/she will 
continuously stick to the treatment during 7 days but can opt out of the trial of 
her own conscious discretion.                                                              Yes/No     
 
I will include patient having atleast 2 to 4 symptoms.   
 
EXCLUSION CRITERIA:        
          • Allergic Rhinitis 
          • Bronchitis 
          • Bronchial Asthma 
          • Severe Diarrhea with other complications 
                                                               
ADMITTED TO TRIAL: 
 
 




                            If yes,                              OPD/IPD                    
 
 




Signature of the Guide                                                        Signature of the Investigator    
                  
 
 
                
                          GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “MANJANAATHI KUDINEER CHOORANAM” IN THE 
TREATMENT OF                        
“NEER KANA MAANTHAM” (ACUTE NASOPHARYNGITIS) IN CHILDREN 
 
FORM II -HISTORY TAKING PROFORMA 
 
1. SERIAL NO. OF THE CASE: ……......   2. OP/IP ..................................... 
3. NAME: ………………………………  4. AGE: ……....... 5. GENDER: ……......... 
5. F. OCCUPATION: …………………    6. F. INCOME:   …………………....... 
7. COMPLAINTS & DURATION:   
 
8. PERSONAL HISTORY: 
 
9. HISTORY OF PREVIOUS ILLNESS: 
 
10. BIRTH HISTORY: 
 
11. DIETARY HABIT: 
             1.Vegetarian              
             2.Non-vegetarian 
12. FAMILY HISTORY: 
               Whether this problem runs in family? 
                                         1. Yes                               2. No        
 
 
If yes, mention the relationship of affected person(s) ____________________________ 




Date:          




                                    








GOVERNMENT SDIDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “MANJANAATHI KUDINEER CHOORNAM” IN THE 
TREATMENT OF  
         “NEER KANA MAANTHAM‟‟ (ACUTE NASOPHARYNGITS) IN 
CHILDREN 
                                             FORM III ASSESSMENT PROFORMA 
 
1. SERIAL NO: ………………….........  
2. OP / IP NO: ........................................................  
3. NAME: ……………………………........   4.AGE: …….....     5.GENDER: ................            
          
GENERAL EXAMINATION: 
Height (cms)                : ………………………….                   
Weight (kg)    : ………………………….                   
Temperature(°F)     : ………………………….                   
Pulse rate(/min)   : ………………………….                   
Heart rate(/min)   : ………………………….                   
Respiratory rate(/min)  : ………………………….                   
Blood pressure(mm/Hg)      : ………………………….      
      
 







Jugular vein pulsation 
 
SYSTEMIC EXAMINATION 
CardioVascular System  : ………………………….                   
 
Respiratory system   : ………………………….                   
 
Gastro-intestinal system  : ………………………….                   
 
Central Nervous System  : ………………………….                   
 
Urogenital system   : ………………………….                   
 




SIDDHA SYSTEM OF EXAMINATIONS: 
1. THEGI:  [BODY CONSTITUTION]  
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal  
2. NILAM:  [LAND WHERE PATIENT LIVED MOST] 
   1. Kurinji    (Hilly terrain)                                   
   2. Mullai    (Forest range)                       
    3. Marutham    (Plains)                            
4. Neithal     (Coastal belt)                    
5. Paalai  (Arid regions) 
3. KAALAM: 
1. Kaar kaalam                               4.Pinpani kaalam      
2. Koothir kaalam                           5. Ilavenil kaalam 
3. Munpani kaalam                           6.Muthuvenil kaalam 
4. GUNAM: 
           1.Sathuvam                2.Raasatham             3.Thaamatham 
5. IMPORIGAL (SENSORY ORGANS): 
                                                                        Normal / Affected 
Mei  ----------------------------------------------- 
Vaai  ----------------------------------------------- 
Kann  ------------------------------------------------ 
Mukku ------------------------------------------------ 
Sevi  ------------------------------------------------ 
6. KANMENDHIRIYAM (MOTOR ORGANS): 
Kai  ----------------------------------                
Kal  ------------------------------------ 
Vaai   ------------------------------------ 
Eruvai ---------------------------------- 
Karuvaai --------------------------------- 
7. KOSANGAL (SHEATH): 
Annamaya kosam ------------------------ 
Pranamaya kosam -------------------------- 
Manomaya kosam ------------------------------- 
Vignana maya kosam ----------------------------- 
Anandamaya kosam ------------------------------- 
8. UYIR THAATHUKKAL: [THREE HUMORS] (VALI, AZHAL, IYAM) 
A) VALI 
 Pranan ________________________  
Abanan ________________________ 
Samanan ________________________  
Uthanan ________________________  
Vyanan ________________________  
Naagan ________________________  
Koorman ________________________  
Kirukaran ________________________  
Devathathan  ________________________ 
Dhananjayan ________________________ 
B) AZHAL 
           Analakam ________________________ 
           Ranjakam ________________________ 
          Sathakam ________________________  
         Prasakam  ________________________ 
         Alosakam  ________________________ 
C) IYAM 
          Avalambagam _______________________ 
          Kilethagam __________________________ 
         Pothagam  _________________________ 
         Tharpagam  __________________________ 
         Santhigam __________________________ 
9. SEVEN UDAL THATHUKKAL: (SEVEN SOMATIC COMPONENTS)  
     Saram ___________________________ 
     Senneer ___________________________ 
     Oon  ___________________________ 
     Koluppu  ___________________________ 
     Enbu  ___________________________ 
     Moolai  ___________________________ 
     Sronitham ___________________________ 
 
10. ENVAGAI THERVU: 
I. NAADI: [PULSE PERCEPTION]         
II. SPARISAM: [PALPATION] 
III. NAA: [TONGUE] 
              IV. NIRAM: [COMPLEXION]   
1. Vadham         
2. Pitham 
3. Kabam  
            V. MOZHI: [VOICE] 
            1. High Pitched 
            2. Low Pitched 
            3. Medium Pitched 
 
           VI. VIZHI: [EYES] 
 
        VII. MALAM: [BOWEL HABITS / STOOLS] 
          Niram 
          Irugal 
          Ilagal 
          Others 
      VIII. MOOTHIRAM [URINE EXAMINATION]   
NEERKKURI: 
        Niram 
        Manam 
        Edai 
        Nurai 
        Enjal 
                                  NEIKKURI: 
 




  Signature of the Guide                                            Signature of the Investigator   
                      
GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
POST- GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
CLINICAL STUDY ON “MANJANAATHI KUDINEER CHOORNAM” IN THE 
TREATMENT OF 
“NEER KANA MAANTHAM‟‟ (ACUTE NASOPHARYNGITIS) IN CHILDREN 
FORM IV:  LABORATORY INVESTIGATIONS PROFORMA 
1. SERIAL NO. OF THE CASE:  ………........  
2.OP / IP NO:......................................   
3. NAME: ……………………………   4.AGE: ……     5.GENDER: .................   
 






Hb (gm/dL)   
Absolute eosinophil count ( Cells/ul)   
ESR (mm) ½ hr.   
 
1 hr.   





  Lymphocytes   
  Monocytes   
  Eosinophils   
  Basophils   






Albumin   
Sugar   




















GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
    CLINICAL STUDY ON “MANJANAATHI KUDINEER CHOORNAM” IN THE 
TREATMENT OF                   
 “NEER KANA MAANTHAM‟‟ (ACUTE NASOPHARYNGITIS) IN CHILDREN 
FORM V: INFORMED CONSENT FORM 
“I have read the foregoing information, or it has been read to me. I have the 
opportunity to ask questions about it to my satisfaction. 
            I consent voluntarily to participate my child in this study and understand that I 
have the right to withdraw my child from the study at any time without in any way it 
affecting my child further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date: 
Signature of the participant: 
In case of illiterate participant 
  “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has the opportunity to ask questions. I confirm that the 
individual has given consent freely.”                                                   
            Date: 
            Signature of a witness                              Left thumb Impression of the Participant     
              (Selected by the participant bearing no connection with the survey team)       
Date:    
Station:                                                                                  
Signature of participant:                                                 
Signature of the Guide                                                       Signature of the Investigator 
GOVERNMENT SIDDHA MEDICAL COLLEGE, CHENNAI 
  CLINICAL STUDY ON “MANJANAATHI KUDINEER CHOORNAM” IN THE 
TREATMENT OF  
         “NEER KANA MAANTHAM‟‟ (ACUTE NASOPHARYNGITS) IN CHILDREN 
                                         FORM VI - WITHDRAWAL FORM 
                                    
SI NO  :                 
OP / IP NO :                                               
NAME : 
AGE / GENDER:                
DATE OF TRIAL COMMENCEMENT  : 
DATE OF WITHDRAWAL FROM TRIAL : 
REASONS FOR WITHDRAWAL: 
• Long absence at reporting :                                    Yes/ No 
• Irregular treatment:                                                Yes/ No 
• Shift of locality :                                                    Yes/No 
• Increase in severity of symptoms:                         Yes/No 
• Development of severe adverse drug reactions:    Yes/No 
 
 




    Signature of the Guide                                                  Signature of the Investigator   
GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
  CLINICAL STUDY ON “MANJANAATHI KUDINEER CHOORNAM” IN THE 
TREATMENT OF  
         “NEER KANA MAANTHAM‟‟ (ACUTE NASOPHARYNGITS) IN 
CHILDREN 
 
FORM VII – PATIENT INFORMATION SHEET 
 
Name of Co- Investigator: M.Haripriya               Name of the college:  
                                                                                     Govt.Siddha Medical  College 
                                                                                     Arumbakkam 
                                                                             Chennai-106. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL 
             M.Haripriya studying M.D (Siddha) at Govt. Siddha Medical College, Chennai, is 
doing a clinical trial on “MANJANAATHI KUDINEER” in the treatment of „„NEER 
KANA MAANTHAM” – ACUTE NASOPHARYNGITS in children. 
It is becoming a most common disease, occurring throughout the world.  In this regard, I 
am in need to ask you few questions. I will maintain confidentiality of your comments and 
data obtained. There will be no risk of disclosing your identity and no physical, 
psychological or professional risk is involved by taking part in this study. Taking part in 
this study is voluntary.  No compensation will be paid to you for taking part in this study. 
           You can choose not to take part. You can choose not to answer a specific question. 
There is no specific benefit for you if you take part in the study. However, taking part in 
the study may be of benefit to the community, as it may help us to understand the 
problem of defaulters and potential solutions. 
          If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal medicine 
„„MANJANAATHI KUDINEER " (Internal medicine)  for 7days.  
  The information I am collecting in this study will remain between you and the Co- 
investigator (myself). I will ask you few questions through a questionnaire. I will not 
write your name on this form. I will use a code instead. 
The questionnaire will take approximately 20 minutes of your time. 
If you wish to find out more about this study before taking part, you can ask me 
all the questions you want or contact M.Haripriya, PG Scholar cum Co- investigator of 
this study, attached to Government Siddha Medical College, Chennai-106. You can also 
contact the Member-secretary of Ethics committee, Govt. Siddha Medical College, 
Chennai. 
 








                                GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “MANJANAATHI KUDINEER CHOORNAM” IN THE 
TREATMENT OF  
         “NEER KANA MAANTHAM‟‟ (ACUTE NASOPHARYNGITIS) IN 
CHILDREN 
FORM X - ADVERSE REACTION REPORTING FORM 
 
SERIAL NO :                                                                                                           
OP/IP NO : 
NAME :                                                     AGE:                 GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF OCCURRENCE OF THE ADVERSE REACTION:  TIME: 





Date:                                                                              
Station: 
 
Signature of the Guide                                                 Signature of the Investigator      
 
அ஧சு சித்஡ ஥ருத்து஬க் கல்லூரி, பசன்கண-106 
அநிஞர் அண்஠ா ஥ருத்து஬஥கண, பசன்கண. 
஢ீர்க்க஠ ஥ாந்஡ம் ந஢ாய்க்கான் சித்஡ ஥ருத்஡ின் (஥ஞ்ச஠ாத்஡ிக் குடி஢ீர்) 
தரிகரிப்புத் ஡ிநளணக் கண்டநிம௃ம் ஥ருத்து஬ ஆய்஬ிற்கான் ஡க஬ல் தடி஬ம். 
எப்பு஡ல் தடி஬ம் ஆய்஬ாப஧ால் சான்நபிக்கப்தட்டது 
 
஢ான் இந்஡ ஆய்ள஬ குநித்஡ அளணத்து ஬ித஧ங்களபம௃ம் ந஢ா஦ாபிக்கு 
புரிம௃ம் ஬ளக஦ில் ஋டுத்துள஧த்ந஡ன் ஋ண உறு஡ி஦பிக்கிநநன். 
ந஡஡ி:                          ளகச஦ாப்தம்: 
இடம்:                         சத஦ர்: 
ந஢ா஦ாபி஦ின் சதற்நநார் எப்பு஡ல் தடி஬ம் 
஋ன்ணிடம் இந்஡ ஥ருத்து஬ ஆய்஬ின் கா஧஠த்ள஡ம௃ம், ஥ருந்஡ின் ஡ன்ள஥ 
஥ற்றும் ஥ருத்து஬ ஬஫ிமுளந தற்நிம௃ம், ச஡ாடர்ந்து ஋ணது உடல் இ஦க்கத்ள஡ 
கண்கா஠ிக்கவும், அ஡ளண தாதுகாக்கவும் த஦ன்தடும் ஥ருத்து஬ ஆய்வுக்கூட 
தரிநசா஡ளணகள் தற்நி ஡ிருப்஡ி அபிக்கும் ஬ளக஦ில் ஆய்வு ஥ருத்து஬஧ால் 
஬ிபக்கிக் கூநப்தட்டது. 
஢ான் ஋ணது கு஫ந்ள஡஦ின் இந்஡ ஥ருத்து஬ ஆய்஬ின் நதாது, கா஧஠ம் ஋துவும் 
கூநா஥ல், ஋ப்சதாழுத்஦ ந஬ண்டு஥ாணாலும் இந்஡ ஆய்஬ினிருந்து ஋ணது 
கு஫ந்ள஡஦ின் ஬ிடு஬ித்து சகாள்ல௃ம் உரிள஥ள஦ ச஡ரிந்஡ிருக்கின்நநன். ஢ான் 
஋ன்னுளட஦ சு஡ந்஡ி஧஥ாக ந஡ர்வு சசய்ம௃ம் உரிள஥ள஦க் சகாண்டு ந஢ாய்க்காண 
஥ஞ்ச஠ாத்஡ிக் குடி஢ீர் ஥ருந்஡ின் தரிகரிப்புத் ஡ிநளணக் கண்டநிம௃ம் ஥ருத்து஬ 
ஆய்஬ிற்கு ஋ன்ளண உட்தடுத்஡ எப்பு஡ல் அபிக்கிநநன். 
ந஡஡ி:        ளகச஦ாப்தம்: 
இடம்:        சத஦ர்: 
ந஡஡ி:                         சாட்சிக்கா஧ர் ளகச஦ாப்தம்: 
இடம்:                           சத஦ர்: 
உநவுமுளந: 
துளநத்஡ளன஬ர் ளகச஦ாப்தம்:                ஆ஧ாய்ச்சி஦ாபர் ளகச஦ாப்தம்:        
          அ஧சு சித்஡ ஥ருத்து஬க் கல்லூரி, பசன்கண-106 
           அநிஞர் அண்஠ா ஥ருத்து஬஥கண, பசன்கண. 
஢ீர்க்க஠ ஥ாந்஡ம் ந஢ாய்க்கான் சித்஡ ஥ருத்஡ின் (஥ஞ்ச஠ாத்஡ிக் குடி஢ீர்)  
தரிகரிப்புத் ஡ிநளணக் கண்டநிம௃ம் ஥ருத்து஬ ஆய்஬ிற்கான் ஡க஬ல் தடி஬ம். 
 
ஆ஧ாய்ச்சி஦ாபர் சத஦ர்   : ஥.ஹரிப்திரி஦ா. 
஢ிறு஬ணத்஡ின் சத஦ர்   : அ஧சு சித்஡ ஥ருத்து஬க் கல்லூரி 
                             அரும்தாக்கம், சசன்ளண-106. 
 
அ஧சு சித்஡ ஥ருத்து஬க் கல்லூரி஦ில் தட்ட ந஥ற்தடிப்பு த஦ின்று ஬ரும் ஢ான் 
஥ருத்து஬ர். ஥.ஹரிப்திரி஦ா. ஢ீர்க்க஠ ஥ாந்஡ம்  ஋ன்னும் ந஢ா஦ில் ஥ருத்து஬ 
ஆ஧ாய்ச்சி஦ில் ஈடுதட்டுள்நபன். 
         இந்஡ ந஢ாய் கிரு஥ிகபிணால் ஋ற்தடுகின்நண. இது த஧஬க் கூடி஬ ந஢ாய். 
         இந்஡ ஆ஧ாய்ச்சி சம்தந்஡஥ாக சின நகள்஬ிகளபக் நகட்கவும், ந஡ள஬஦ான் 
ஆய்஬கப் தரிநசா஡ளணக்கு ஡ங்களப உட்தடுத்஡வும் உள்நபன். 
         இந்஡ ஆ஧ாய்ச்சிக்கு ஡ங்கள் ஬ிருப்தத்஡ின் நதரில் உட்தடும் தட்சத்஡ில் 
உள்஥ருந்஡ாக ஥ஞ்ச஠ாத்஡ிக் குடி஢ீர் 2 ந஬ளப(காளன, ஥ாளன) உ஠வுக்கு தின்              
7 ஢ாட்கள் உட்சகாள்ப  ந஬ண்டும். 
         இந்஡ ஥ருந்து சிநப்தாக ஢ீர்க்க஠ ஥ாந்஡ம் ந஢ாய்க்காக அங்கீகரிக்கப்தட்ட 
சித்஡ ஥ருத்து஬ த௄னில் கூநப்தட்டுள்பது. 
         இந்஡ ஆ஧ாய்ச்சி஦ில் ஡ங்களப அனு஥஡ித்஡ திநகு உங்கல௃க்கு ஬ிருப்தம் 
இல்ளனச஦ணில் ஋ப்நதாது ந஬ண்டு஥ாணாலும் ஆ஧ாய்ச்சி஦ில் இருந்து ஬ினகிக் 
சகாள்ப உரிள஥ உள்பது. 
         இந்஡  ஆ஧ாய்ச்சி சம்தந்஡஥ாக ந஢ா஦ின் ஡ன்ள஥ தற்நிம௃ம் ஥ற்ந 
஬ித஧ங்கல௃க்கும் ஆ஧ாய்ச்சி஦ாபர் ஥ருத்து஬ர் : ஥.ஹரிப்திரி஦ா (தட்ட ந஥ற் 
தடிப்தாபர் கு஫ந்ள஡ ஥ருத்து஬ துளந) அ஬ர்களப ஋ந்஡ ந஢஧த்஡ிலும் ச஡ாடர்பு 
சகாள்பனாம். ளகப்நதசி ஋ண் : 8220321809. 
       ந஥லும் இந்஡ ஆ஧ாய்ச்சிக்கு ஡க்க அனு஥஡ிச் சான்று( IEC ) சதநப்தட்டுள்பது. 
         இந்஡ ஥ருந்து முற்நிலும் தாதுகாப்தாண மூனிளக சதாருட்களபக் சகாண்டு 
஡஦ாரிக்கப்தட்டுள்பது . தக்க ஬ிளபவுகளப ஌ற்தடுத்஡ாது. 
         ந஥லும் உ஠வு முளந஦ில் ஥ருத்து஬஧ால் கூநப்தடும் தத்஡ி஦ம் காக்கு஥ாறு 
அநிவுறுத்஡ தடுகிநது. 
இது சம்தந்஡஥ாண ஡ங்கபது அளணத்து ஬ி஬஧ங்கல௃ம் ஧கசி஦஥ாக 
ள஬க்கப்தடும் ஋ண உறு஡ி அபிக்கிநநன். 
             இ஡ில் த஦஠ப்தடி மு஡னி஦ ஋ந்஡ உ஡஬ித் ச஡ாளகம௃ம் ஬஫ங்கப் தட 
஥ாட்டாது. 
இந்஡ ஆ஧ாய்ச்சி஦ின் நதாது உடலுக்கு ந஬று தா஡ிப்பு ஌ற்தடும் தட்சத்஡ில் 
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